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Over the last few decades researchers have attempted to explore the relationship 
between perfectionism and Chronic Fatigue Syndrome (CFS). Both cognitive 
behavioural and psychodynamic models of CFS include perfectionism as a key 
contributory factor in this condition. This review investigates the empirical evidence 
for a relationship between perfectionism and fatigue to inform psychological models 
of CFS. A systematic search of five electronic databases (SCOPUS, PubMed, 
PsychNET, Science Direct and Web of Science) was performed, yielding 726 
articles; 20 of which met the inclusion criteria. This review provides a synthesis and 
critical evaluation of the literature, drawing on multi-dimensional models of 
perfectionism. Findings provide support for the psychological models of CFS, 
indicating that perfectionism is significantly associated with fatigue, typically with 
small to moderate correlations (r=.12-.44). More specifically, negative perfectionism 
and in some cases positive perfectionism are positively correlated with fatigue. 
Prospective research supports the role of perfectionism as a potential risk factor for 
fatigue and there is some evidence to suggest the role of depression and repetitive 
negative thought in this relationship. Psychological interventions, such as cognitive 
behavioural therapy (CBT) focussing on the remediation of perfectionism, may be of 
benefit to patients with CFS. Furthermore, clinicians may benefit from paying 
greater attention to depression and repetitive negative thinking, given their potential 
role in mediating the relationship between perfectionism and fatigue. 
 
Keywords: Perfectionism; Chronic Fatigue Syndrome; Fatigue; Cognitive 












Clinical aspects of Chronic Fatigue Syndrome  
 
Chronic Fatigue Syndrome (CFS) is a debilitating condition, characterised by 
persistent and unexplained fatigue of at least six months duration, resulting in severe 
impairments in daily functioning (Holmes et al., 1988; Sharpe et al., 1991). Although 
the predominant feature, fatigue is often accompanied by a range of other symptoms 
including generalised muscle pain, headaches and post exertional malaise (Fukuda et 
al., 1994). Prevalence estimates in the general population range from 0.5% to 2.5% 
(Reeves et al., 2007), with the average age of onset between 30 and 40 years (Jason 
et al., 1999; Lloyd, Hickie, Boughton, Spencer, & Wakefield, 1990).  
 
The term CFS and the criteria for diagnosing the disease were introduced in 1988 
(Holmes et al., 1988). Prior to this point, a number of illnesses with symptoms 
similar to those of CFS were reported, these included: neurasthenia, post-viral or 
post-infectious fatigue, Myalgic Encephalomyelitis (ME), Immune Dysfunction 
Syndrome and Royal Free disease (Wessely, 1994).  
 
Causes and maintenance factors 
 
Over the years there has been much debate surrounding the etiology of CFS, with a 
number of theories having been proposed. Earlier theories focussed on the 
occurrence of symptoms suggestive of a psychiatric disorder or acute viral illness. 
However, subsequent studies have also indicated differences in a number of areas 
including brain structure and function, neuroendocrine response, immune function, 
and psychological attributes (Afari & Buchwald, 2014; Balachander, Rao, Sarkar, & 
Singh, 2014). There is evidence that CFS is unlikely to be caused by just one 
etiological factor but rather is multi-factorial (Wessely, Sharpe, & Hotopf, 1998). A 
bio-psycho-social model may explain the development of CFS, where disability 
results from the interplay between various predisposing and perpetuating factors. 





Cognitive behavioural and psychodynamic models of CFS 
 
As previously noted, within the biopsychosocial model of CFS, one factor that may 
have a perpetuating and even predisposing role are the personality traits of those 
with the condition. The cognitive behavioural model of CFS by Surawy, Hackmann, 
Hawton and Sharpe (1995) provides one possible explanatory framework for 
understanding how personality traits may interact with an organic insult, such as an 
acute illness, to precipitate a cycle of psychological and behavioural responses that 
result in the development and maintenance of CFS.  
 
According to the cognitive behavioural model, individuals at risk of developing CFS 
are thought to have pre-morbid personalities characterised by “a marked 
achievement orientation, perfectionism, high standards of work performance, 
responsibility and personal conduct” (Surawy et al., 1995, p.537). They are said to 
have a propensity to place great emphasis on the opinions of others, striving to meet 
their own and others’ expectations.  
 
When faced with an event that challenges their ability to perform, assumptions 
regarding achievement, strength and personal worth are activated leading to an 
increase in activity. In the context of CFS, the precipitating event (e.g., acute illness) 
is said to place demands on the individual, leading to a depletion of personal 
resources and affecting their ability to cope. In an attempt to improve their situation, 
the individual tries to increase their level of activity, working hard to meet their 
desired goals. Unfortunately, this only leads to an exacerbation of symptoms and a 
subsequent reduction in activity.  
 
According to the cognitive model, once a state of fatigue is established, cognitive, 
behavioural, emotional, physiological and social factors may act to perpetuate it. 
Importantly, the individual searches for an explanation for their fatigue. For many, 
concerns about the cause of their symptoms may favour a biological explanation. As 
time passes, repeated experiences of failure and fears of exacerbating symptoms 
serve to reinforce beliefs that the individual must have a chronic disease, resulting in 
emotional distress (e.g., anxiety and depression), inactivity and abandonment of 
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efforts to meet previous standards. The model suggests that it is the physiological 
changes that accompany this chronic state of emotional distress and inactivity that 
result in the ongoing symptoms of fatigue, poor concentration and muscle pain. 
 
Psychodynamic theorists have furthered this, arguing that self-critical perfectionism 
may play a role in the precipitation and perpetuation of CFS by impacting adversely 
on the stress system and stress response. Van Houdenhove, Van Den Eede and 
Luyten (2009) hypothesised that the pathophysiological basis of CFS could involve a 
“switch” of the stress system from a state of over-drive to under-drive, leading to 
persisting impairments in the stress response and associated changes in pain 
regulation mechanisms and abnormal inflammatory activity. These researchers 
argued that this ‘switch’ results from chronic periods of over-activity, often triggered 
by an emotional and/or physical event. Further, they hypothesised that self-critical 
perfectionism may be one driving force behind high levels of over-activity. Thus, 
according to the cognitive and psychodynamic models, perfectionism is a key 




Perfectionism was described by Hollender (1978) as “the practice of demanding of 
oneself or others a higher quality of performance than is required by the situation” 
(p.384, as cited in Shafran, Cooper, & Fairburn, 2002). Debate remains in the 
research literature as to the exact nature of the perfectionism construct. Initially 
described as a personality trait it has since been generally accepted as a cognitive 
process, involving the setting of high standards. Some researchers have maintained 
that perfectionism is uni-dimensional (i.e., clinical perfectionism; see Shafran, et al., 
2002) while others have proposed that it is multi-dimensional (Frost, Marten, Lahart, 
& Rosenblate, 1990; Hewitt & Flett, 1991; Hewitt, Flett, Turnbull-Donovan, & 
Mikail, 1991), existing in multiple subtypes and presentations. 
 
Factor analytic studies of the two main measures of perfectionism (both known as 
the Multi-dimensional Perfectionism Scale, MPS: Frost et al., 1990, Hewitt & Flett, 
1991) typically indicate a two-factor model. In a recent analysis of existing studies, 
Dunkley, Blankstein, Masheb and Grilo (2006) concluded that perfectionism is 
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comprised of two related but independent factors. These are ‘personal standards,’ 
characterised by high self-standards and achievement striving, and ‘evaluative 
concerns,’ characterised by self-doubt and self-criticism. The former is linked to 
adaptive outcomes and the latter to maladaptive outcomes. This two-factor model, 
closely relates to the concepts of ‘positive’ or ‘healthy’ and ‘negative’ or ‘unhealthy’ 
perfectionism (Frost, Heimberg, Holt, Mattia, & Neubauer, 1993; Slade & Owens, 
1998; Stumpf & Parker, 2000).  
 
In the wider literature, positive perfectionism has been associated with high self-
esteem and conscientiousness (Campbell & Di Paula, 2002; Stumpf & Parker, 2000). 
Conversely, negative perfectionism has been significantly correlated with a wide 
range of psychopathology including clinical depression, anxiety and eating disorders 
(Bardone-Cone et al., 2007; Fairburn, Cooper, & Shafran, 2003; Shafran & Mansell, 
2001). 
 
The assessment of perfectionism 
 
Two of the most widely used measures of perfectionism are the Frost 
Multidimensional Perfectionism Scale (Frost MPS: Frost et al., 1990) and the Hewitt 
and Flett Multidimensional Perfectionism Scale (Hewitt and Flett MPS: Hewitt & 
Flett, 1991).  
 
The Frost MPS provides a score for six dimensions of perfectionism as well as a 
total score. The six dimensions are conceptually labelled as Concerns over Mistakes 
(CM), Personal Standards (PS), Parental Criticism (PC), Parental Expectations (PE), 
Doubts about Actions (DA), and Organisation (O). The Frost MPS has been found to 
have good evidence of construct, concurrent and discriminant validity. The internal 
consistency of the subscales range from .77 to .93 and is .90 for the total 
perfectionism score (Frost et al., 1990). 
 
The Hewitt and Flett MPS comprises of three dimensions: Self-Orientated 
Perfectionism (SOP: this reflects setting high standards for oneself), Socially 
Prescribed Perfectionism (SPP: this reflects an individual’s concerns regarding 
others’ high expectations) and Others Orientated Perfectionism (OOP: this reflects 
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setting high standards for others). Evidence supports the test–retest reliability, 
factorial validity, predictive validity, and discriminant validity of the Hewitt and 
Flett MPS (e.g., Hewitt & Flett, 2004). The internal consistency for the subscales 
ranges from .74 to .88 (Hewitt & Flett, 1991). 
 
In the past few decades, additional multi-dimensional perfectionism measures have 
emerged with adequate psychometric properties and different conceptualisations of 
perfectionism. The Almost Perfect Scale-Revised (APS-R: Slaney, Rice, Mobley, 
Trippi, & Ashby, 2001) is an empirically and factor analytically derived scale 
(Suddarth & Slaney, 2001; Wang, Yuen, & Slaney, 2009) assessing maladaptive and 
adaptive perfectionism. It includes a discrepancy scale to determine distress caused 
by the mismatch of standards and performance. Factor structure, reliability, and 
validity of APS–R scores have been supported in several studies, with internal 
consistency of subscales ranging from .80 to .90 (e.g., Grzegorek et al., 2004; Rice & 
Ashby, 2007). The Positive and Negative Perfectionism Scale (PANPS: Terry-Short, 
Owens, Slade, & Dewey, 1995) is an alternative measure, based on a two factor 
distinction between ‘normal’ and ‘neurotic’ perfectionism. Internal consistency for 
the subscales ranges from .81 to .83 (Haase & Prapavessis, 2004). Finally, the Child 
and Adolescent Perfectionism Scale (CAPS: Flett, Hewitt, Boucher, Davidson, & 
Munro, 1997 as cited in O’Connor, Dixon, & Rasmussen, 2009); derived from the 
Hewitt and Flett MPS (1991), is a commonly used measure of perfectionism in the 
childhood literature comprising of two dimensions, SOP and SPP. The CAPS has 
shown to have good internal consistency properties and adequate 1 week test–retest 
reliability (Castro et al., 2004). 
 
Other measures which include assessment of perfectionism 
Other measures that include an assessment of perfectionism include the  
Dysfunctional Attitudes Scale (DAS: Weissman & Beck, 1978) and the Depressive 
Experiences Questionnaire (DEQ: Blatt, D’ Afflitti, & Quinlan, 1976). The DAS is a 
measure of dysfunctional attitudes proposed to play a role in depression. It has a 
consistent two factor structure measuring (a) social approval and (b) perfectionism. 
The DEQ has been used by some researchers as a measure of self-critical 
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perfectionism and interpersonal dependency, and has good psychometric properties 
(Blatt, 2004; Luyten et al., 2011).  
 
Aim of the current review 
 
The most recent review of the relationship between perfectionism and CFS (van 
Geelen, Sinnema, Hermans, & Kuis, 2007) concluded that there was inconsistent 
evidence to support the role of perfectionism in CFS. This review however focused 
on personality broadly, not perfectionism specifically, and findings were limited to 
patients with a clinical diagnosis of CFS. Further, since this review, the area of 
perfectionism research in fatigue has expanded significantly. This new body of 
research warrants a comprehensive examination. 
 
The current review sought to provide a synthesis and critical evaluation, drawing on 
views in the literature that perfectionism in CFS may be more clearly distinguished 
utilising a two-factor model of perfectionism, characterised by positive and negative 
components (e.g., Kempke et al., 2011a). To the author’s knowledge, this is the first 
review specifically exploring the relationship between perfectionism and CFS. It is 






An extensive systematic literature search was conducted and a key word search of 
articles indexed in the SCOPUS, PubMed, PsychNET, Science Direct and Web of 
Science databases was performed on 1
st
 January 2015. No date restrictions were 
applied. The computerised search used the following strategy: (perfect OR 
perfectionism OR perfectionistic) AND (fatigue OR “chronic fatigue” OR “chronic 
fatigue syndrome”). Search terms were subjected to thesaurus mapping in PubMed 





Inclusion and exclusion criteria 
 
Each article was screened for inclusion according to the following criteria: the article 
(i) included a standardised measure of perfectionism and fatigue, (ii) explored the 
relationship between perfectionism and fatigue (iii) was classified as primary 
research, (iv) was published in a peer-reviewed journal and (v) was published in the 
English language. Book chapters, conference abstracts, case studies, review articles, 
dissertation and theses abstracts were excluded from the search.  
 
There is some evidence to suggest that fatigue is continuously distributed in the 
population (e.g., Pawlikowska et al., 1994) and therefore some of the factors 
contributing to CFS as suggested by the cognitive-behavioural model, may also be at 
work in fatigue at the less severe end of the spectrum (Lewis & Wessely, 1992). If 
this is the case then studies looking at perfectionism and fatigue in non-clinical 
samples may allow for predictions made by clinical models of CFS to be tested. 
With this in mind, the search included both clinical (i.e., patients meeting CFS 
criteria) and non-clinical (e.g., student) populations, and cross-sectional, case-control 
and prospective studies. 
 
Selection of studies 
 
The initial database search yielded 957 articles: 726 after duplicates were removed. 
The titles and abstracts were then screened for inclusion. In cases where it was not 
clear from the abstract whether the article met inclusion criteria, the full-text article 
was reviewed. Electronic searches were supplemented by hand-searching reference 
































Figure1. Flow chart of study selection 
Records identified through 
database searching  
(n = 957) 
Duplicates removed  
(n =231) 
Records screened 
(abstract and title)  
(n =726) 
Full-text articles 
assessed for eligibility  
(n = 22) 
Records excluded 
(n = 704) 
Full-text articles 
excluded 
(n = 3)  
Relationship between 
perfectionism and 
fatigue was not 
measured (n=3) 
 
Studies included in the 
review  







(n = 1) 
 






This section seeks to synthesise key findings of the studies included in the current 
review in order to establish whether there is a relationship between the construct of 
perfectionism and CFS. See Tables 1 and 2 for a summary of findings. 
 
Cross-sectional correlational studies 
 
Non-clinical groups 
Five cross-sectional correlational studies exploring the relationship between 
perfectionism and fatigue in non-clinical samples were identified. Magnusson, Nias 
and White (1996) revealed significant small to moderate correlations between 
negative perfectionism (DA, PE) and increased mental and physical fatigue (r =.19-
.30, p<.05) in a sample of 121 female nursing staff. Further, findings indicated a 
trend for positive aspects of perfectionism (i.e., PS) to be inversely related to 
tiredness, suggesting positive perfectionism may have a protective effect against 
fatigue.  
 
Saboonchi and Lundh (2003) explored the relationship between perfectionism and 
somatic health in a population sample of 184 Swedish adults. Findings indicated that 
both positive and negative aspects of perfectionism (SOP and SPP) showed small but 
significant positive correlations (r=.18-.20, p<.05) with self-reported somatic 
complaints, specifically the 'Tension/Fatigue' subscale of the Somatic and Emotional 
Experiencing Inventory (SEEI: Lundh & Simonsson‐Sarnecki, 2001). Further, the 
relationship between SPP and ‘Tension/Fatigue’ was significant only for women, 
raising the question “To what extent is the relationship between perfectionism and 
somatic complaints gender specific?”. The relationship between negative 
perfectionism and fatigue was further supported by Macedo et al. (2009) who found 
a small positive correlation between SPP and fatigue symptoms (r = .23, p<.001) in 
a sample of 421 pregnant women.  
 
 




Arpin-Cribbie and Cribbie (2007) attempted to shed further light on the relationship 
between perfectionism and fatigue by examining different components of fatigue 
(fatigue-related emotional distress, somatic symptomology, general fatigue and 
cognitive difficulties) separately. In a large sample of undergraduate students 
(N=307), perfectionism was found to significantly correlate with fatigue-related 
emotional distress (β = 0.13, p<.05) and cognitive difficulties (β = 0.18, p<.05) but 
not with general levels of fatigue or somatic symptomology. Depression and 
automatic negative thoughts were found to correlate more strongly than 
perfectionism with all four components of fatigue, suggesting that they may be more 
significant contributors to fatigue. Although these findings are interesting, this study 
is limited in that the analyses did not look at the individual dimensions of 
perfectionism; rather a composite measure was employed.   
Finally, Macedo et al. (2015) investigated the potential mediating role of repetitive 
negative thinking in the relationship between perfectionism and fatigue in a sample 
of 788 university students. Perfectionism was measured utilising two composite trait 
perfectionism dimensions: Evaluative Concerns (EC) and Positive Striving (PS) 
derived from the Portuguese versions of the Frost MPS (Amaral et al., 2013) and the 
Hewitt and Flett MPS (Macedo et al., 2007). Findings revealed a moderate 
correlation between negative perfectionism (i.e., EC) and increased fatigue (r = .44, 
p<.01). When entered into a hierarchical regression model after perceived stress and 
social support, perfectionism scores (EC and PS) were found to account for 
additional variance in fatigue. Furthermore, mediation analyses revealed repetitive 
negative thinking to be a partial mediator of the relationship between negative 
perfectionism (EC) and fatigue and a full mediator of the relationship between 
positive perfectionism (i.e., PS) and fatigue. These findings suggest that the effect of 
negative perfectionism on fatigue was potentiated by repetitive negative thinking. In 
the case of positive perfectionism, a relationship with fatigue only existed when high 
levels of repetitive negative thinking were also present.  
 
Summary 
The findings support the role of perfectionism as a consistent correlate of fatigue 
with repetitive negative thinking as a potential mediator in this relationship (Macedo 
et al., 2015). More specifically, the effects of negative perfectionism on fatigue 
 




appear to be exacerbated by repetitive negative thinking and in the case of positive 
perfectionism, repetitive negative thinking is a necessary condition to the association 
between perfectionism and fatigue.   
 
It is important to note however that most correlations reported above were small to 
moderate (r=.18-.44) and there is some evidence to suggest other factors as stronger 
overall correlates of fatigue (e.g., depression, negative automatic thoughts; Aprin-
Cribbie & Cribbie, 2007). Further, given the cross-sectional nature of the above 
studies, it is not possible to draw any conclusions about the direction of the 
association between perfectionism and fatigue.  
 
Clinical groups 
Three cross-sectional correlational studies exploring the relationship between fatigue 
and perfectionism in a clinical sample of CFS patients were identified. Brooks, 
Rimes and Chalder (2011) explored the role of negative perfectionism, lack of 
acceptance and depression in predicting fatigue among a sample of 259 CFS 
patients. Correlational analyses revealed a small but significant relationship between 
negative perfectionism and fatigue (r= .16, p<.05). In a stepwise regression, with 
fatigue as the dependent variable and DA and lack of acceptance as predictor 
variables, DA was found to be the only significant predictor. When regression 
analyses were run again, including depression scores, depression was found to be the 
only significant predictor of fatigue when DA and depression were entered. 
 
Kempke, Van Houdenhove et al. (2011) utilised a structural equation modelling 
framework, to investigate whether positive or negative perfectionism were 
differentially associated with severity of depression and fatigue in a large group 
(N=192) of CFS patients. Perfectionism was measured using the Dutch version of 
the Frost MPS, divided into positive (PS subscale) and negative (CM and DA 
subscale) factors. Correlational analyses revealed small to moderate correlations 
between negative perfectionism and fatigue (r=.22-.36, p<.001). Further, a model 
was supported in which negative (i.e., high levels of self-criticism and self-doubt) 
but not positive perfectionism (i.e., high personal standards) was significantly and 
positively related to severity of fatigue and depression. Moreover, the results 
 




supported a full mediation model in which depression fully mediated the effect of 
negative perfectionism on fatigue.  
 
Valero, Sáez-Francàs, Calvo, Alegre and Casas (2013), utilising a similar sample 
(N=299 CFS patients) and study design, investigated the relationship between 
negative perfectionism, fatigue and depression while also exploring the potential role 
of a fourth variable, neuroticism. Correlational analyses revealed significant positive 
correlations between all variables. The lowest effect observed was the moderate 
correlation between severity of fatigue and negative perfectionism (r = .39, p<.01), 
while the largest correlation was between severity of depression and fatigue (r = .65, 
p<.01). The authors failed to provide support for the findings of Kempke, Van 
Houdenhove et al. (2011), reporting that a model connecting negative perfectionism 
to fatigue through depression was not supported according to the indexes of 
goodness of fit. Rather, in the context of the multivariate analysis, a model was 
supported in which neuroticism predicted fatigue severity through depression.  
 
It is important to note that there were two primary differences between these two 
studies that may have accounted for some of the discrepancies found. Firstly, the 
studies utilised different fatigue measures (see Table 2). Valero et al. (2013) 
measured the impact of fatigue on daily functioning whereas Kempke, Van 
Houdenhove et al. (2011) measured fatigue severity.  Therefore, it may be that the 
two studies were not measuring equivalent constructs of fatigue, accounting for the 
difference in findings.  
 
Secondly, as noted above, Valero et al. (2013) included neuroticism as an alternative 
explaining factor. Perfectionism and neuroticism are highly correlated constructs 
(e.g., Dunkley, Blankenstein, & Berg, 2012). It could be argued that perfectionism 
may well be reasonably integrated within the neuroticism construct, and thus in 
competition with the effects of neuroticism, the relationship between perfectionism 










Cross-sectional research supports a relationship between negative perfectionism and 
fatigue in CFS patients. Further, findings by Kempke, Van Houdenhove et al. (2011) 
suggest the role of depression as a potential mediator in this relationship, although 
this was not supported in a similar study by Valero et al. (2013). Valero et al. (2013) 
proposed that neuroticism may be a more consistent factor than negative 
perfectionism in the conceptualisation of CFS severity; further research would be 
needed to confirm this. 
 
All three studies employed samples from tertiary care. Although this implies a 
rigorous diagnostic protocol, it may have biased the sample towards a more severe 
clinical profile making generalising findings difficult. Furthermore, although the two 
latter studies utilised more sophisticated methods of analysis in the form of structural 
equation modelling, the cross-sectional nature of the studies precludes the ability to 
make causal conclusions.  
 
Case Control Studies 
 
CFS patients vs. healthy controls 
Four studies compared perfectionism levels between individuals with CFS and 
healthy controls. White and Schweitzer (2000) utilised a sample of 44 CFS patients 
and 44 healthy controls, matched on age and gender. Findings indicated that the CFS 
group reported higher levels than the controls on total and negative perfectionism 
(DA and CM). This finding was supported by Deary and Chalder (2010) who 
reported higher levels of negative perfectionism (CM, DA, PC), anxiety and 
depression in patients with CFS (N=27) compared to healthy controls (N=30).  
 
Conversely, Blenkiron, Edwards and Lynch (1999) found that perfectionism scores 
were lower in their CFS sample (N=40), reflecting fewer perfectionistic traits than 
the control group (N=31), particularly on measures of OOP. The authors proposed 
that lower perfectionism scores among those with CFS may have reflected 
individuals’ attempts to moderate their perfectionistic tendencies and standards to 
adjust to their condition. However, given that no measures of pre-morbid 
 




perfectionism were taken it is not possible to confirm this. In the most recent study, 
Rimes, Papadopolous, Cleare and Chalder (2014) failed to find a difference in 
perfectionism scores (as measured using the CAPS; Flett et al., 1997) between their 
sample of 49 adolescents with CFS and 36 healthy controls.  
 
Summary 
In summary, the evidence is mixed with regard to whether patients with CFS exhibit 
greater perfectionistic tendencies than their healthy counterparts. Given the limited 
number of studies it is difficult to draw any firm conclusions. All studies utilised 
small sample sizes, increasing the likelihood of sampling error i.e., chance or random 
error in the choice of a representative sample compared with the total population 
under consideration. In addition, differences in study design, such as the use of 
different questionnaires may have yielded inconsistent findings, making it difficult to 
compare and draw conclusions from these studies. 
 
A major limitation in each of the above studies was the lack of direct assessment of 
pre-morbid perfectionism. As such, it cannot be certain whether patients with CFS 
were more or less perfectionistic prior to their diagnosis or whether their levels of 
perfectionism reflected a reaction to their ongoing fatigue. This methodological 
weakness could be addressed in future studies by utilising a prospective design.  
 
All studies utilised healthy rather than illness control groups and three restricted their 
patient sample to predominately white female populations with a high degree of 
education. Although the latter demographics reflect the characteristics of many 
secondary and tertiary care CFS patients, these findings may not be representative of 
the CFS population in primary care or the community. It would be of value to 
investigate perfectionism in a population of newly diagnosed CFS patients; such an 
investigation may lead to a better understanding of the role of perfectionism in the 











Luyten,Houdenhove, Cosyns and Van den Broeck (2006) utilised a retrospective 
case-control design to investigate the relationship between premorbid and post-
morbid perfectionism, fatigue and depression in a sample of 43 CFS patients and 80 
student controls. In so doing the authors aimed to gain further clarity on the role of 
perfectionism in the development of CFS. The authors utilised a Flemish-Dutch 
version of the Frost MPS; a modified version of the Frost-MPS used to measure 
premorbid perfectionism (“pre-illness MPS-F”).  
 
Results indicated that CFS patients scored significantly higher than students on both 
positive (PS and O) and negative (DA, CM) premorbid perfectionism. After illness 
onset, CFS patients continued to show significantly higher scores on both negative 
(DA) and positive (O) perfectionism subscales. However, scores on PS and CM were 
significantly lower, suggesting that the CFS patients lowered their personal standards 
and showed less concern over mistakes following illness onset. This finding appears 
in line with some previous research suggesting that patients with CFS may 
experience fewer perfectionistic beliefs post-diagnosis (e.g., Blenkiron et al., 1999). 
 
Inherent in a retrospective study design are problems related to social desirability, 
inaccurate and selective recall. Further evidence for the hypothesis that 
perfectionism is a potential candidate influencing the onset or course of CFS must be 
more rigorously tested using prospective designs. Further, these findings need to be 
replicated in studies comparing CFS patients with community patients and other 
patient groups. 
 
CFS patients vs. patients with other chronic conditions 
Do individuals with CFS have higher levels of perfectionism than individuals with 
other chronic conditions? This question raises the issue of specificity: is there a 
special relationship between perfectionism and CFS or is this personality trait a 
factor in other types of chronic illness?  
 
Two studies have explored this issue. Wood and Wessely (1999) explored whether 
specific personality traits and social attitudes characterised CFS patients. One 
 




hundred and one CFS patients and 45 patients with rheumatoid arthritis took part in 
the study. No statistically significant differences were found between groups on 
personality measures, including perfectionism (as assessed using the Frost MPS). 
The stereotype of CFS patients as perfectionists was not supported when compared 
with patients suffering from another physically disabling illness.  
 
In a recent study, Sirosis and Molnar (2014) compared levels of perfectionism across 
three patient groups (CFS, Irritable Bowel Syndrome and Fibromyalgia/arthritis) and 
a healthy control group. In contrast to the findings of Wood and Wessely (1999), 
negative perfectionism (as measured using the APS-R; Slaney et al., 2001) was 
found to be higher among the CFS group relative to the other chronic conditions and 
healthy controls. The authors took this finding to suggest the importance of negative 
perfectionism in CFS. It is important, however, to note that whereas the first study 
(Wood & Wessley, 1999) utilised clinical populations, the second study recruited 
through a population based survey in which participants’ self-reported diagnosis. 
The lack of a medically-screened sample in the latter study may account for the 
difference in findings and may bring into question the validity of the findings.  
 
Summary 
Only two studies to date have explored the issue of specificity, with conflicting 
results. These studies have varied in terms of the samples used, methods of 
recruitment and measures of perfectionism; as such no clear conclusions can be 
drawn. Further research, utilising a range of medically-screened clinical comparison 
groups, including individuals with other chronic medical health complaints as well 




Non-clinical prospective studies 
Two prospective studies were identified which explored the role of perfectionistic 
beliefs in the development of fatigue in non-clinical samples. The first study utilised 
a sample of undergraduate students while the other, a sample of academic 
employees. Dittner, Rimes and Thorpe (2011) investigated whether negative 
 




perfectionism would serve as a vulnerability factor for the development of fatigue in 
the context of increased stress. Perfectionism was measured utilising two trait 
perfectionism dimensions: Conditional Acceptance (CA) and Perfectionist Striving 
(PS), derived from the Hewitt and Flett MPS. Fatigue was assessed using visual 
analogue scales (of both mental and physical fatigue) and the Chalder Fatigue Scale 
(Chalder et al., 1993). Students were asked to complete measures of perfectionism 
and fatigue both at the beginning of the academic year (T1) and again following a 
time of academic pressure, 16 weeks later (T2). Findings indicated that participants 
were significantly more fatigued at T2 than at T1. Negative perfectionism (i.e., CA) 
was correlated with all measures of fatigue at T1 (r=.12-.16, p<.05) and predicted 
subsequent levels of fatigue after controlling for T1 fatigue. Furthermore, positive 
perfectionism (i.e., PS) was found to be negatively correlated with fatigue in the 
cross-sectional analysis (r=-.13, p<.01).  
 
Regression analyses were also carried out to investigate whether there was a 
correlation between T1 negative perfectionism and a range of variables hypothesised 
to mediate the relationship between negative perfectionism and fatigue (stress, 
depression, unhelpful academic behaviours, and health behaviours). The only 
significant correlation was between T1 negative perfectionism and T2 depression. 
Furthermore, mediation analyses revealed that depression mediated the relationship 
between negative perfectionism and subsequent physical fatigue.  
 
In the second prospective investigation, Flaxman, Ménard, Bond and Kinman (2012) 
explored the impact of perfectionism on fatigue and well-being in a sample of 77 
academic employees. Participants were divided into perfectionistic and non-
perfectionistic groups, based on their scores on the DA subscale of the Frost MPS 
(MPS-DA; Frost et al., 1990). Fatigue was assessed using the Warr’s (1990) 
Affective Well-being Scales (see Daniels, Brough, Guppy, Peters‐Bean, & 
Weatherstone, 1997). Participants were asked to complete questionnaire measures 2 
weeks prior to (T1), during (T2) and on two occasions after (T3; 2 weeks post-
respite and T4; 5 weeks post-respite) a 4-day respite from work. Findings revealed 
that in post-respite working weeks, academics exhibiting negative perfectionism 
(i.e., DA) reported significantly higher levels of fatigue (r=.28-.40, p<.05). Further, 
 




the relationship between negative perfectionism and fatigue was mediated through 
the tendency for perseverative thinking (e.g., worry and rumination) about work 
during respite itself.  
 
Summary 
In summary, two non-clinical studies provide support for the role of negative 
perfectionism in predicting the development of fatigue symptomology. Further, like 
previous research (Kempke, Van Houdenhove et al., 2011; Macedo et al., 2015), 
findings support the role of depression and associated processes (e.g., perseverative 
negative thinking) as mediators in this relationship.  
 
Clinical prospective studies  
To date, only two prospective studies have attempted to explore the relationship 
between perfectionistic beliefs and CFS using clinical samples. Moss-Morris, Spence 
and Hou (2011) explored whether psychological factors proposed in the cognitive 
behavioural model of CFS could predict the onset of chronic fatigue (fatigue at 3 
months) and CFS (fatigue at 6 months) following an acute episode of glandular 
fever. Patients (N=246) who agreed to participate in the study completed a baseline 
questionnaire at the time of their acute infection (T1) which included a range of 
potential risk factors for CFS (including perfectionism, mood, perceived stress, 
somatisation, illness beliefs and behaviour). Patients were followed-up at 3 (T2) and 
6 months (T3). Findings revealed that negative perfectionism (as measured using the 
negative subscale from the PANPS; Slade & Owens, 1998) was a risk factor for the 
development of CFS at 6 months follow-up. A number of other variables were also 
significant predictors at both 3 and 6 months (anxiety, depression, somatisation, 
negative illness beliefs and all-or-nothing behavioural patterns), suggesting the 
involvement of multiple factors in the development of fatigue (Wessely et al., 1998). 
Although an interesting finding, it is important to take into consideration that the 
above model was only tested in one ‘at risk’ sample (post-glandular fever CFS) 
therefore generalisability of these findings to the wider group remains to be 
determined. Furthermore, diagnosis of CFS was not reached through clinical 
assessment but was self-reported. Thus, these findings should be interpreted with 
some caution.  
 




In a recent study, Kempke et al. (2013) investigated whether negative perfectionism 
(referred to in the study as self-critical perfectionism) could prospectively predict 
daily symptoms of fatigue in a sample of 99 CFS patients. Unlike previous research, 
this study employed a daily diary method procedure in which patients were asked to 
rate their average daily fatigue levels using a visual analogue scale (VAS). Results 
indicated that negative perfectionism (as measured using the DEQ) prospectively 
predicted fatigue levels over a 14-day period. This effect remained significant even 
when controlling for depression. Given this research utilised an already fatigued 
sample, insight into the role of perfectionism in the onset of fatigue is not provided; 




There is currently minimal prospective research investigating the relationship 
between perfectionism and fatigue using clinical samples. To date, only one study 
Moss-Morris, Spence and Hou (2011) has investigated whether perfectionism may 
be a genuine risk factor for the development of CFS, despite this being the 
fundamental assumption of the cognitive-behavioural and psychodynamic models for 
the development of CFS.  Further, the findings of this study indicate that although a 
contributory factor, perfectionism may be one of a number of variables important in 
the development of fatigue. This fits with a biopsychosocial model of CFS which 




To date, research evidence supports the efficacy of CBT and graded exercise therapy 
(GET) in the treatment of CFS (see meta-analyses; Castell, Kazantzis, & Moss‐
Morris, 2011; Edmonds, McGuire, & Price, 2004; Malouff, Thorsteinsson, Rooke, 
Bhullar, & Schutte, 2008; Price, Mitchell, Tidy, & Hunot, 2008). Although a number 
of these studies (e.g., Chalder, Tong, & Deary, 2002; Sharpe et al., 1996) have 
purported to address negative perfectionism as part of the treatment, only one to date 
has explored change in perfectionism levels over the course of intervention. Brooks, 
Rimes and Chalder (2011) investigated the effectiveness of a short-term (12 week, 
 




fortnightly) CBT intervention in reducing negative perfectionism and improving 
acceptance among a sample of 90 CFS patients. It was hypothesised that negative 
perfectionism (CM and DA) would reduce over the course of therapy. Outcome 
measures were completed at pre-, post and 3-months follow-up. 
 
As predicted, findings indicated that CM was significantly lower at discharge and 
follow-up, and DA lower at discharge only. Scores on the PC and PE subscales did 
not change significantly after treatment. The authors argued that this was 
unsurprising given that CBT would be more focussed on addressing current high 
standards and evaluative concerns than on perceptions of parental standards.  
 
Given that this change took place within the context of a non-randomised cohort 
study with no control group, it cannot be concluded that the intervention was 
necessarily responsible for the reduction in symptoms. Comparison with an untreated 
CFS group would be necessary to clarify whether change in perfectionism scores 
could have been due to natural course or engagement in treatment.  
 
Perfectionism as a predictor of treatment outcome  
 
Lloyd, Chalder, Sallis and Rimes (2012) explored perfectionism as a predictor of 
outcome (specifically fatigue severity and school attendance) following a 6 session, 
telephone-based guided self-help CBT intervention for CFS in adolescent youths. 
Findings indicated that higher baseline levels of SOP and SPP (as measured using 
the CAPS; Flett et al., 1997) were significantly associated with increased odds of 
having an improved outcome for school attendance. Baseline perfectionism was not 




















120 men,  
187 women, 
Mean age= 19.7 
(SD = 4.0) 
Two sub-scales (SOP 
and SPP) from the 
MPS-H 
 
Two subscales (social 
approval and 
perfectionism) from the 
DAS. 
PFRS Perfectionism significantly correlated with 
fatigue-related emotional distress (β = 0.13, 










308 women, 128 
men, 
Mean age = 20.4 
(SD=5.3) 
 
Two subscales (CA and 
PS) from the four 





and the CFQ 
Negative perfectionism (i.e., CA) was correlated 
with all measures of fatigue at T1 (r=.12-.16, 
p<.05) and predicted subsequent levels of fatigue 
after controlling for T1 fatigue.  Positive 
perfectionism (i.e., PS) was found to be 
negatively correlated with fatigue (r=-.13, p<.01). 
Depression mediated the relationship between 








49 women, 28 men, 
Mean age= 46 (SD 
=10) 
DA subscale of the 
MPS-F 
Fatigue 





Academics exhibiting negative perfectionism 
(i.e., DA) reported significantly higher levels of 
fatigue (r=.28-.40, p<.05) during post-respite 
working weeks. Further, the relationship between 
negative perfectionism and fatigue was mediated 
through the tendency for perseverative cognition 






Summary of Non-Clinical Studies  
Clinical Groups 
 




Note. MPS-F = Multi-dimensional perfectionism scale-Frost; MPS-H = Multi-dimensional perfectionism scale – Hewitt & Flett; SOP = Self Orientated 
Perfectionism; SPP = Self Prescribed Perfectionism; DAS = Dysfunctional Attitudes Scale; PFRS = Profile of Fatigue-Related Symptoms; CFQ = Chronic 
Fatigue Questionnaire; CA = Conditional Acceptance; PS = Perfectionist Striving; DA = Doubts about Actions; POMS = Profile of Mood States; SEEI = 
Somatic and Emotional Experiencing Inventory.










Mean age =29.8 
(SD=4.5; range=19-
44 years) 
Two sub-scales (SOP 
and SPP) from the 
Portuguese version of 
the MPS-H  
Fatigue 
subscale of the 
Portuguese 
version of the 
POMS 
Small positive correlation between negative 
perfectionism (SPP) and fatigue symptoms (r 









572 women,  
216 men 
Mean age = 20.3 
(SD = 2.0; range = 
17–25 years) 
Portuguese versions of 
the MPS-F and the 
MPS-H 
Fatigue-interia 
subscale of the 
POMS 
Moderate correlation between negative 
perfectionism (i.e., EC) and increased fatigue (r 
= .44, p<.01). Perfectionism scores (EC and PS) 
accounted for additional variance in fatigue over 
perceived stress and social support. Repetitive 
negative thinking mediated relationship between 





121 nurses All women 
Median age = 25 
(range = 21-56 
years) 




Significant small to moderate correlations 
between negative perfectionism and increased 








102 women, 80 men 
Mean age = 37 (SD 
= 7.4 men, SD = 8.1 
women) 
MPS-H  Tension/ 
Fatigue 
subscale of the 
SEEI 
Positive and negative perfectionism showed small 
but significant positive correlations (r=.18-.20, 
p<.05) with self-reported somatic complaints, 
specifically the 'Tension/Fatigue' subscale. 
 

















CFS group = 24 
women, 16 men, 
Mean age = 49 
(range 21-66 years) 
Healthy control 
group = 18 women, 
13 men, Mean age = 
40 (range 21-68 
years) 
MPS-H CFQ Perfectionism scores were lower in the CFS 
sample (N=40), reflecting fewer perfectionistic 
traits than the control group, particularly on 

















195 women, 64 
men, Mean age = 
39.2 years 
(SD=11.9; range = 
18–80 years). 
Four negative 
subscales (CM, DA, PE 
and PC) from the MPS-
F  
CFQ Small but significant relationship between 
negative perfectionism (specifically DA) and 
fatigue (r= .16, p<.05). Following 6 sessions of 
CBT, CM was significantly lower at discharge 
and follow-up, and DA lower at discharge only. 
Scores on the PC and PE subscales did not 








All women CFS 
group = Mean age = 
41.2 (SD = 8.9), 
Healthy control 
group = Mean age = 






CFS group reported significantly higher levels 




Summary of Clinical Studies 
Clinical Groups 
 














164 women, 28 men 
Mean age = 40.2 
years (S.D.=9.4, 
range 19–66 years) 
Two negative subscales 
(DA, CM) and one 
positive subscale (PS) 
from the MPS-F 
 
The Dutch 
version of the 
CIS-20 
Correlational analyses revealed small to moderate 
correlations between negative perfectionism and 
fatigue (r=.22-.36, p<.001). The results supported 
a full mediation model in which depression fully 
mediated the effect of negative perfectionism on 
fatigue. 
 




92 women, 7 men, 
Mean age = 41.7 
years (S.D.=8.7, 
range 18–59 years) 
Self-critical 
perfectionism subscale 





Negative perfectionism prospectively predicted 
fatigue levels over a 14-day period. This effect 
remained significant even when controlling for 








14 girls, 9 boys, 





CFQ A significant decrease in fatigue was found 
between pre-treatment and 6 month follow-up. A 
significant increase in school attendance was 
found between pre-treatment and 6 month follow-
up. Univariate logistic regression found baseline 
perfectionism to be associated with improved 












CFS group = 37 
women, 6 men, 
Mean age = 39.1.  
Students = 67 
women, 13 men, 
Mean age 21.4. 
MPS-F and modified 
pre-illness MPS 
The Dutch 
version of the 
CIS-20 
Results indicated that CFS patients scored and 
negative premorbid perfectionism. After illness 
onset, CFS patients continued to show 
significantly higher scores on both negative and 




















152 women, 94 
men, Mean age = 
22.8 (S.D =8.3)  
The negative subscale 
from the PANPS 
Centers for 
Disease Control  
or British 
criteria were 
used to identify  
CFS cases. 
9.4% met the criteria for Chronic Fatigue (CF) at 
3 months and 7.8% met the criteria for CFS at 6 
months. 
Perfectionism was associated with new-onset 













CFS group = 31 
girls, 18 boys, Mean 
age = 14.9 (SD= 
1.7) 
HC group = 21 
girls, 15 boys, Mean 




CFQ No significant difference in perfectionism scores 










CFS group = Mean 
age 32.8 (range 
30.5-35.0); IBS 
group= Mean age 
37.5 (range 35.4-
39.7 years); 
FM/arthritis group = 
Mean age 38.9 
(range 36.1-41.6 
years); HC group = 
Mean age 31.1 
(range 9.4-32.7 
years) 
APS-R No self-report 
fatigue scales 
used 
Perfectionism was found to be higher among the 
CFS group relative to the other chronic 





























209 women,  
20 men, Mean age = 
48.21 years  
(SD = 8.93, range  
22–73 years) 
Two negative subscales 
(DA, CM) and one 
positive subscale (PS) 
from the MPS-F 
U-FIS Moderate correlation between severity of fatigue 
and negative perfectionism (r = .39, p<.01). A 
model connecting negative perfectionism to 
fatigue through depression was not supported. 
Rather, a model was supported in which 










12 men, 32 women, 
Mean age= 43.27 
(range = 18- 67 
years) (groups did 
not differ sig. on age 
or gender) 
MPS-F No self-report 
fatigue scales 
used  
CFS group reported significantly higher levels 
than the controls on total and negative 










CFS Group = 40 
men, 61 women, 
Mean age = 36.6 
(SD = 10.5) 
RA Group = 9 men, 
36 women, Mean 
age = 42.2 (SD = 
9.6) 
MPS-F No self-report 
fatigue scales 
used 
No statistically significant differences in 
perfectionism were found between the two 
groups. 
 
Note. MPS-F = Multi-dimensional perfectionism scale-Frost; MPS-H = Multi-dimensional perfectionism scale – Hewitt & Flett; OOP = Others Orientated 
Perfectionism; CFQ = Chronic Fatigue Questionnaire; DA = Doubts about Actions; CM = Concerns about Mistakes; PS = Parental Standards; PE = Parental 
Expectations; PC = Parental Criticism; APS-R = Almost Perfect Scale – Revised; PANPS = Positive and Negative Perfectionism Scale; U-FIS = Uni-
 




dimensional Fatigue Impact Scale; CIS-20 = Checklist Individual Strength-20; DEQ = Depressive Experiences Questionnaire; CAPS = Child and Adolescent 
Perfectionism Scale; IBS = Irritable Bowel Syndrome; FM = Fibromyalgia
 






This review provides a critical overview and synthesis of findings published in 
studies pertaining to the relationship between perfectionism and fatigue. Overall, the 
majority of studies provide support for the cognitive and psychodynamic models of 
CFS. Findings from cross-sectional research indicate that perfectionism is 
significantly correlated with fatigue, typically with small to moderate associations 
(r=.12-.44). More specifically, findings indicate that negative aspects of 
perfectionism (e.g., CM, DA and SPP) and in some cases positive perfectionism 
(e.g., PS, SOP) are positively correlated with fatigue symptomology. This suggests 
that fatigue may be one context in which ‘positive’ perfectionism may become 
maladaptive. Positive perfectionism reflects the active striving for high standards and 
achievement: in the context of chronic illness, such traits may lead to over-striving 
and the perpetuation of symptoms. 
 
Case-control studies comparing perfectionism in CFS patients with healthy 
participants or illness control groups have revealed less consistent findings, with 
some indicating elevated levels of negative perfectionism among CFS patients, while 
others reported lower levels of perfectionism or no significant differences between 
groups. The reason for this variability is unclear but contributing factors are likely to 
include differences in sample size and composition as well differences in measures 
of perfectionism and fatigue.  
 
Only four prospective studies have explored the role of perfectionism in the 
development of fatigue. Their results are consistent with the suggestion that 
perfectionism may be a potential risk factor for fatigue, although it is likely to be one 
of several contributory factors. One retrospective study found that people with CFS 
report higher levels of perfectionism premorbidly. This may suggest that once the 
condition has developed, individuals are either unable to maintain their previous high 
standards or choose to modify them.  
 
In recent years, researchers have begun using more complex models of analysis to 
explore mediating factors in the relationship between perfectionism and fatigue. 
 




These findings indicate the role of depression as a significant correlate of fatigue and 
where the study design has allowed, depression and repetitive negative thinking have 
been revealed as potential mediators in the relationship between perfectionism and 
fatigue. These findings are consistent with previous research that has found negative 
perfectionism to be associated with depression (Hewitt & Flett, 1993) and repetitive 
negative thinking (Burns & Fedewa, 2005; Frost et al., 1997; Kobori & Tanno, 2005) 
as well as evidence that psychological distress/depression is associated with 
increased fatigue (Pawlikowska et al., 1994; van Geelen et al., 2007).  
 
One preliminary study has explored the impact of CBT for perfectionism on fatigue 
symptomology, indicating positive results. Further, one study investigated the impact 
of perfectionism as a predictor of outcome (specifically fatigue severity and school 
attendance). Contrary to prediction, perfectionism was not found to predict post-
intervention fatigue and was associated with improved school attendance. This 
finding is in contrast to other studies: for example in eating disorders, results have 
shown  perfectionism to be associated with poorer outcome (Bizeul, Sadowsky, & 





The majority of studies utilised a cross-sectional design which constrains inferences 
as to a causal role for perfectionism in the development of fatigue. Indeed, this may 
reflect the embryonic nature of the research field in this area, with most studies 
conducted within the last 10 years. A prospective design was employed in only a 
limited number of cases: such designs are prerequisite for determining if 
perfectionism is a true risk factor for fatigue.  
 
Although the majority of studies employed one of the recognised perfectionism 
scales, some authors chose to exclude some subscales or conduct analyses using an 
aggregate score for perfectionism. While this is often needed due to administrative 
constraints, it creates problems when comparing results. Further, using single 
subscales as a measure of negative or positive perfectionism may call into question 
the reliability of the findings. Flaxman et al. (2012) reported that the DA-subscale of 
 




the Frost MPS (used as their single measure of negative perfectionism) demonstrated 
surprisingly low internal consistency (α = .65).  One resolution of this issue would be 
to develop shortened versions of the scales. 
 
This review highlighted a lack of consistency between measures of fatigue. Indeed, 
across the twenty studies, eleven different measures of fatigue were used. Although 
findings were fairly consistent regardless of the measure employed, it is important to 
make note of the quality of these assessment tools. Some studies utilised validated 
measures of fatigue whereas others used visual analogue scales or subscales within 
more general measures of mood and somatic complaints which have yet to be 
validated in larger scale studies.  Moreover, as with measures of perfectionism, the 
variation in measures of fatigue means that it is difficult to make direct comparisons 
between studies. Scales differed in focus, with some measuring fatigue severity only, 
whereas others looked at the nature of fatigue and the impact on functioning. 
Furthermore, non-clinical studies relied exclusively on self-report measures of 
fatigue and this may have inflated observed relationships. Future studies would 
benefit from alternative collection approaches, such as multiple informant measures 
or physiological measures of fatigue.  
 
Non-clinical studies utilised a range of adult samples including female nursing staff, 
academic employees, undergraduate students, and pregnant mothers. Conversely, 
studies utilising CFS patients tended to be relatively homogenous, with a propensity 
towards Caucasian female patients accessing secondary or tertiary care services. 
Future studies, utilising samples of male participants as well as newly diagnosed 
CFS patients and general population samples would be useful in broadening our 
understanding of the relationship between perfectionism and fatigue.  
 
It should be noted that two of the reviewed studies comprised of adolescent samples 
(Lloyd, Chalder, Sallis, & Rimes, 2012; Rimes, Papadopolous, Cleare, & Chalder, 
2014). Given that adolescents will be in a different developmental phase to the adult 
population, it is plausible that there may be different contributory factors when 
looking at the relationship between perfectionism and fatigue (Fry & Martin, 1996). 
 




Caution should therefore be taken when combining the findings from both 
adolescent and adult samples.  
 
Only six studies employed control groups: four utilised healthy individuals, and two 
utilised individuals experiencing chronic illness. As such, it is not clear whether the 
results of these studies are specific to CFS or may be true for other chronic illnesses 
or the general population. Further, most of these studies had small sample sizes, 
reducing the statistical power to identify true differences and increasing the 
likelihood of sampling error. Additional understanding as to the specific role of 
perfectionism in the development of CFS will require the inclusion of other clinical 
comparison groups including clinical and population based samples and larger 
sample sizes.  
 
Future directions for perfectionism and CFS research 
 
With the previous suggestions for improvement withstanding, a number of future 
directions for perfectionism and CFS research are worthy of note. Further research is 
necessary to determine whether perfectionism accounts for unique variance in CFS 
over and above other predictive factors, whether perfectionism interacts with other 
variables to explain CFS and to identify the mechanism(s) underpinning the link 
between perfectionism and CFS.  
 
This review highlighted the role of depression and repetitive negative thinking as 
mediators in the relationship between perfectionism and fatigue. However, further 
research is needed to determine the mechanisms that may underpin this relationship. 
For example, it could be hypothesised that repetitive negative thinking regarding the 
discrepancies between the individual’s current and premorbid levels of performance 
lead to a reduction in self-esteem and subsequent depression. There is some evidence 
to suggest the role of self-esteem as a mediator in the relationship between 
perfectionism and depression in individuals with CFS (Kempke, Luyten et al., 2011). 
Further research on this topic is needed. 
 
 




Further, there is evidence to suggest that repetitive negative thinking leads to 
sustained stress-related physiological and emotional arousal (Brosschot, Gerin, & 
Thayer, 2006). It could be hypothesised that prolonged repetitive negative thought 
regarding ones condition and its implications may cause a ‘switch’ in the stress 
system from a state of over-drive to under-drive, leading to the development of 
fatigue. Exploring this mechanism in future research is a noteworthy proposal. 
 
Finally, despite studies exploring the relationship between perfectionism and fatigue, 
only one so far has explored the impact of psychological intervention for 
perfectionism among CFS patients (Brooks, Rimes, & Chalder, 2011). Given that the 
research to date highlights perfectionism as a potential risk and maintenance factor in 
fatigue, it makes sense that treatment studies should be further explored. Future 
treatment research should focus on tailoring interventions to directly address the 
factors proposed to contribute to the development and maintenance of perfectionism, 
such as depression and repetitive negative thought. Further, research should focus on 
utilising more robust methodology (e.g., RCT’s) to bring about new insights into the 
treatment of perfectionism, and the impact of this on fatigue. 
 
Limitations of the review 
 
There were several limitations regarding this review. First, potential eligible studies 
were assessed for inclusion by the first author only. In addition, no measures of 
methodological quality were taken. Furthermore, there may have been a publication 





This review indicates that perfectionism is related to fatigue, in line with both 
cognitive and psychodynamic models of CFS. The application of psychological 
interventions, such as CBT for the remediation of perfectionism among CFS patients 
therefore warrants further research. Furthermore, clinicians may benefit from paying 
greater attention to depression and repetitive negative thinking, as these variables 
 




have been shown to have a potential role in mediating the relationship between 
perfectionism and fatigue.  
 
Although these findings are encouraging, caution is needed. Research exploring the 
role of perfectionism in the development and maintenance of fatigue is currently in 
its infancy. Further research seeking to replicate findings and to conduct prospective 
and experimental investigations is needed if we are to determine more clearly the 
potency of perfectionism, mechanisms of action and the causal relations. Further, 
research is needed to explore the relationship between fatigue and perfectionism 
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Background: Hospitalisation can be stressful for patients and their families. Pre-
hospitalisation information is crucial in establishing a good basis for patient 
satisfaction and cooperation. This qualitative study explored whether parents of 
children with Cystic Fibrosis, admitted to a UK Children’s Hospital, were adequately 
prepared for their child’s admission. Methods: Data were collected from twelve 
parents whose children had been admitted within the last two years for routine 
intravenous antibiotic treatment. Semi-structured interviews were analysed using 
thematic analysis. Results: Four themes emerged from the analysis: the admission, 
the ward as a challenging environment, changes in the parent-professional 
relationship and the parental role in medical care. Parents reported feeling 
unprepared for their child’s admission; the need to receive information addressing 
the medical, practical and psychosocial aspects of admission was emphasised. 
Findings highlighted the adverse effects of inadequate information on the hospital 
experience. Conclusions: Provision of adequate preparatory information is essential 
in reducing parental stress, influencing how future experiences are appraised and 
managed. Effective parent-professional communication and opportunities to 
participate in care will improve parental satisfaction.  
 

















Cystic Fibrosis (CF) is the most common, life-limiting, recessively inherited disease 
in the UK, affecting 1 in 2500 live births (Cystic Fibrosis Trust, 2011). Significant 
advances in medical science have resulted in improved survival rates (Elborn, 1998); 
however, there is presently no cure for CF and the current average life expectancy is 
36.6 years (UK Cystic Fibrosis Registry, 2013).  
 
Patients with CF are required to complete rigorous treatment regimens comprising of 
daily physiotherapy, medication and nutritional monitoring (Eiser, Zoritch, Hiller, 
Havermans, & Billig, 1995). During childhood and early adolescence, parents play 
an integral role in delivering care and facilitating treatment adherence within the 
home environment (Eiser et al., 1995; Modi, Marciel, Slater, Drotar, & Quittner, 
2008). In some instances, hospitalisation for more intensive treatment is required 
(Mattsson, 1972). Many children with CF are admitted to hospital to undergo a 
course of intravenous (IV) antibiotics (lasting 2-3 weeks), in order to manage 
pulmonary exacerbations brought on by ongoing infection (Cystic Fibrosis Trust, 
2009).  
It is well recognised that hospitalisation is a highly stressful experience both for 
patients and their families (Commodari, 2010; Franck, Mcquillan, Wray, Grocott, & 
Goldman, 2010; Litke, Pikulska, & Wegner, 2012). Parents are required to 
familiarise themselves with new settings, routines, negotiate new roles in care and 
manage anxieties regarding their child’s treatment (Verwey, 2008). For parents of 
children with CF, these uncertainties are likely to be especially challenging, given 
their central role in the day-to-day management of their child’s condition 
(Darbyshire, 1992). There may be added stress due to in-hospital segregation 
measures; in place to reduce the possibility of cross-infection (Festini et al., 2006; 
Griffiths, Carzino, Armstrong, & Robinson, 2004). Evidence indicates that in-
hospital segregation is associated with adverse psychosocial outcomes, including 
feelings of isolation and perceived lack of social support (Duff, 2001; Griffiths et al., 
2004; Russo, Donnelly, & Reid, 2006). 
 
 




High parental distress has been identified as a barrier to effective participation in 
child care and can adversely affect the hospitalised child both during (Power & 
Franck, 2008) and after admission (Alisic, Jongmans, van Wesel, & Kleber, 2011; 
Dunn et al., 2012; Kassam‐Adams, Fleisher, & Winston, 2009; Nugent, Ostrowski, 
Christopher, & Delahanty, 2007). It is becoming increasingly recognised that 
informing and preparing parents of what to expect during their child’s hospitalisation 
is crucial in reducing distress and enabling parents to maintain a key role in care 
(Commodari, 2010).  
The National Service Framework for Children, Young People and Maternity 
Services (NSF CYPMS; Department of Health, 2003) has identified this need and 
has set out standards of care highlighting the importance of providing “accurate 
information [regarding hospitalisation] that is valid, relevant, up-to-date [and] 
timely” and doing so “utilising a range of communication methods so that 
information may be made available regarding specific conditions, medicines and 
procedures” (Department of Health, 2003, p. 16). 
Research has shown that preparatory programmes such as the conveyance of detailed 
information in person, via leaflet or DVD have the potential to improve the 
hospitalisation experience for both patients and their families (Buckley & Savage, 





The CF team at the Bristol Royal Hospital for Children (BRHC) have identified a 
need for formal preparation for parents of children with CF prior to their child’s 
inpatient hospital admission for IV antibiotics. This need was identified during a 
team discussion about the inpatient experience. Currently individuals are directed to 
online materials (provided through the University Hospital’s Bristol Website) which 
offer generic practical advice, without reference to more specific aspects addressing 
medical, psychological and social factors. Given the stress associated with child 
hospitalisation, such resources may be insufficient to meet their needs. 
 
 




Questions to be addressed 
  Do parents feel adequately prepared for their child’s initial inpatient hospital 
admission?  
 If not, how can the Bristol CF service better meet the needs of these parents, 
addressing the requirements set out by the NSF CYPMS (Department of 




A qualitative design was employed, through which data generated from semi-
structured interviews were analysed using inductive thematic analysis (Braun & 
Clarke, 2006). Thematic analysis was chosen as the most appropriate qualitative 
method as it is a highly flexible approach that can be used across a range of 
epistemologies and research questions. Thematic analysis provides a reflective 
approach that allows researchers to capture the richness and in-depth nature of 
participants’ experiences and allows for the generation of general themes across the 
data set.  
 
Participants and recruitment 
 
The team’s Clinical Psychologist attempted to contact twelve parent couples for 
interview. Parents had been identified by the team’s Senior Nurse and 
Physiotherapist. Parents were eligible for participation if (i) they had a child who had 
experienced their first inpatient hospital admission (or first inpatient hospital 
admission since infanthood) within the last two years and (ii) the admission had been 
related to the delivery of scheduled IV antibiotics. Parents were excluded from the 
study if their child’s admission was for diagnosis or an emergency procedure. 
Eligibility criteria were developed through discussion with the CF team.  
 
Ten of the twelve parent couples were reached by telephone. Three attempts were 
made to contact the remaining two couples; however this was unsuccessful. Of the 
ten parent couples successfully contacted, all agreed to take part. Parents were sent 
 




an invitation letter, information sheet and written consent form. They were invited to 
return the signed consent forms either by post or on attendance at the CF outpatient 
clinic. Once consent had been obtained, the researcher contacted each parent couple 
via telephone to arrange a face-to-face interview. The option of conducting the 
interview either at the outpatient clinic or in the parents’ home was provided; all 
requested the latter. 
 
On the day of the interview, only the mother of each parent couple was available in 
all but two cases with the primary reason given for absence being work 
commitments. In instances where both parents were available, a joint interview was 
arranged. Parents ranged in age from 35 to 70 years (M= 45.2, SD= 9.8), self-
identified ethnicity was as follows: 11 White British and one Asian British. Children 
ranged in age from 2 to 14 years (M= 8.1, SD =4.1). Ethical approval was obtained 
from the University of Bath Psychology Ethics Committee and the Research and 




Semi-structured interviews took place with each parent (or parent couple) who 
consented. The questions (see Table 1) that formed the topic guide were developed 
iteratively through discussion with the CF Clinical Psychologist and staff team in 
order to elicit information related to the research question. The purpose of the semi-
structured interview was to systematically collect information from parents by asking 
uniform questions, while offering the flexibility for parents to provide additional 
relevant information and allow the interviewer to ask clarifying questions. Interviews 
were conducted by the first author. Interviews were audio-recorded and each lasted 













Semi-structured interview questions 
 Remembering back to your child’s most recent hospital stay, do you feel that 
you were adequately prepared for what to expect, both from a practical and 
emotional perspective?  
o If so, what information/advice did you find helpful? 
o If not, what information and/or support do you think would have been 
helpful? 
 What effect did this preparation (or lack of) have on the admission 
experience? 
 If we were to develop materials that would assist parents in preparing for 
their child’s first hospital stay, what information do you think would be 






The interviews were transcribed verbatim and analysed using Braun and Clarke’s 
(2006) six-phase guide to thematic analysis. The first author read the transcripts 
repeatedly to ensure familiarisation with the data. Initial ideas were noted down and 
the data were then coded. Data with the same codes were collated and sorted into 
identifiable themes and subthemes. Themes were then refined through an iterative 
process whereby themes generated were compared back to the original text and their 
appropriateness and resonance in relation to the research question were reviewed. To 
ensure rigor, a ‘paper trail’ as suggested by Yardley (2008) was kept to identify how 
themes had developed over time. 
 
To promote reliability of the analysis, the themes were verified by the second author, 
an experienced clinical psychologist and researcher within the area of clinical health 
psychology. The second author was provided with a sample of four interview 
transcripts and progressed through the step-by-step analysis process along with the 
 




first author. Once both authors had coded and analysed the interviews, they met to 
discuss their findings and reach a consensus regarding the thematic structure. 
Finally, the third author, who had expertise within the area of CF, was asked to 




There is no definitive set of guidelines for determining reliability and validity of 
qualitative research; however a range of guidelines do exist in the literature (e.g., 
Mays & Pope, 2000; Yardley, 2008). Elliot, Fischer, and Rennie (2001) provide a 
useful set of guidelines which intend to characterise the appropriate considerations 
involved in the conduct and publishability of qualitative research. These specific 
guidelines include: situating the sample (placing the sample in context including 
relevant descriptive data), grounding in examples (providing examples of primary 
data to illustrate themes), providing credibility checks (using methods to check the 
credibility of categories or themes such as the inclusion of multiple analysts or an 
auditor) and ensuring coherence (achieving coherence and integration while 
preserving nuances in the data). These considerations were addressed within the 
current research.  
 
Results 
Four themes emerged from the analysis: the admission, the ward as a challenging 
environment, changes in the parent-professional relationship and the parental role in 
medical care. These themes describe the parents’ ‘journey’ from the clinic to the 
hospital ward and the associated challenges that shaped their perceptions of the 
hospital experience. Pseudonyms have been used to preserve parent anonymity. See 







                                                             
1 Quotes reported within the Table as per the Journal of Cystic Fibrosis formatting  guidelines 
 









1 (1) “I don’t think we were prepared at all. We just were told she 
needed to go in. It was a situation where she had a couple of cough 
swabs done – literally I was scrambling to pack things like items of 
clothing, her medication, and just be prepared for myself to be 
there two weeks.” 
2 (2) “It was all a bit last minute; we didn’t know what was happening” 
3 (3) “It happened quite quickly, for me that was good as I don’t want to 
mull things over too long” 
4 (10) “It was probably better in some ways because your mind isn’t as 
anxious, and your mind isn’t fully on it, so you can just deal with 
it” 
5 (4) “I felt quite sort of overwhelmed by it and the result was that I was 
very keen to put it off, which was not a good thing” 
6 (6) “Naturally you are going to push something like that away, you are 
not going to want to think about a hospital admission” 
7 (4) “She may have given me information that I wasn’t able to take in at 
the time because we’d just come out of an appointment where we’d 
learned she was going into hospital” 
8 (2) “They did not really say what to bring or what to expect, they just 
said you need to bring her medication; that was it really….I felt 
like I was going in completely blind” 
9 (5) “I really felt that the psychological aspects of the admission were 
overlooked, they were not really discussed” 
10 (6) “The nurse explained a little of what to expect but this was mainly 
medical and practical information…. there was nothing about how 
we would feel emotionally” 
11 (2) “We did not know that one of the antibiotics could cause hearing 
loss. We thought, ‘This is something else to worry about; they have 
not told us about this’. We felt we had no control over the 
situation.” 
12 (3) “It would have been nice to have known what they were looking 
for and what it meant if they found ‘secretions’…it would have 
helped me feel a bit more in control as I had not been through it 
before” 
 




13 (5) “I guess the emotional preparation is important: being aware of 
how you are going to feel. It is full of anxiety really: if I went back, 
those first couple of days…fear not just for you but for your child” 
14 (7) “It is hard for parents, especially when it’s their child’s first 
admission. I think helping parents see that what they are 
experiencing is normal would be really helpful” 
15 (1) “There’s no set time… …it is very fluid, and you do end up 
waiting around” 
16 (8) “The nurses and consultants are coming in, administering 
medication; you can’t conform to routine”  
17 (3) “We were lucky, we weren’t on the ward but in our own room so 
had some privacy” 
18 (3) “It is nice because you have your own room, but at the same time 
you’re a bit isolated. I found that having a young child this was 
particularly the case as you have to be with them all the time” 
 
19 (6) “[the nurses were] doing observations during the night and the 
lights were on so it was difficult to feel settled or that you had 
privacy in that room. One of the main things was that there was no 
let-up…it just felt 24/7” 
20 (1) “It can be difficult to sleep. It’s quite light, even when the lights go 
out…because you can hear stuff going on outside. If you don’t 
sleep well, you don’t function well” 
21 (4) “There is the case that you meet parents of older children with 
CF…that was quite scary because I think we all hope treatments 
for CF are going to change radically over the next 10 years but at 
the same time you realise that you are in the same boat as people in 
a really really difficult situation and that can be quite alarming” 
22 (6) “Once you have obviously overcome the shock and are coming 
around to the practicalities of CF, I think it would be useful to have 
a light hearted, informal visit to a ward, which I think would 
manage the fear and help you know what is coming” 
23 (11) “I think maybe perhaps at the time they could have offered us… a 
walk around the ward to see what it was going to be like” 
24 (7) “I’m so used to seeing my team, the Cystic Fibrosis team, and 
when we went in there I thought, ‘Why are they not visiting 
today?’…It was very difficult because they provide so much 
support both medically and emotionally for both you and the kids 
and you don’t really see them” 
25 (5) “You think ‘where are the people from the CF team, they are not 
 




here’….you just want them to say, ‘Hi [parent], how are you 
doing?’” 
26 (8) “The community team are absolutely fantastic. It’s almost like 
most of them have become members of the family” 
27 (2) “I felt we were ignored to a certain degree. I know it’s a patient to 
them but she’s my daughter, I wanted to know she was ok” 
28 (2) “They patched her up and nothing further was explained – we were 
not told what the next steps would be or when we would get the 
results” 
29 (4) “I felt there was a slight tendency for staff to regard as routine what 
is actually an enormous upheaval for a family, particularly when 
you don’t know the ropes” 
30 (1) “When you arrive on the ward you expect to see the same 
physiotherapists, nurses and doctors that you see in clinic. To be 
confronted with a different team is a bit of a shock. I feel it is 
important for parents to know this so that they can prepare 
themselves and adjust their expectations accordingly” 
31 (11) “I like to know because I think I like to maintain as much control 
as possible. When you’re the parent of a child with CF you get 
used to taking an active role in their care” 
32 (4) “You get used to being somebody who’s part of the team looking 
after them and you don’t really want to relinquish that when you go 
into hospital or feel like you have to because you are used to being 
the principal carer in a way” 
33 (2) “Medication and physio was taken out of our hands. I felt like, ‘I 
am her mum: I should be doing these things’. To be running on 
someone else’s timescales was so annoying”  
34 (12)  “It can be frustrating when you feel the drugs have not be given 
how you would like” 
35 (4) “There is a difficulty as a mother when your child goes into 
hospital…your relationship to your child is altered because 
suddenly you defer to the medical staff. I always feel a little bit 
hopeless and stupid when I am in hospital with my child”   
36 (3)  “I guess you get used to your own routine and helping your child 
administer their medications but then it gets taken out of your 
hands, you feel a bit useless” 
37 (9) “I felt I wasn’t in control and I think some of the things that I have 
done have brought back that control a little bit. Just making sure 
that I felt that I understood everything that was going on, and 
having people around me that I could trust and rely on and speak to 
 




about how I felt” 
38 (4) “The advantage of having involvement in care is that after a few 
days we were giving the IV’s ourselves, just being watched by the 
nurses. We felt a cohesion to the team rather than just being a lump 
sitting there in the corner, regretting that our child was in hospital 
and not being able to do anything to make it better” 
39 (10) “At the end of the day you’re in their hands: you go with what they 
want” 
40 (4) “I think as parents…you regard it as a very long-term commitment 
to their health so you want to be as knowledgeable and involved as 
possible. The worst thing is being half involved and half 
knowledgeable” 
 
Theme 1. The admission 
 
In all cases, admissions took place within the context of routine symptom 
monitoring. This meant that the consulting CF physician made a decision, following 
necessary tests and observations, that a hospital admission for IV antibiotics was 
required.   
 
Suddenness of admission 
All parents described a relatively short period of time (i.e., a few days) between 
being informed of the possibility of admission and entering hospital. As a result, the 
admission was perceived as “last minute”, leaving little time to prepare for the 
hospital stay (Quotes 1 and 2, Table 2).  
For two parents, the lack of time to prepare was positively received as it meant that 
they had little time to think things through, reducing anticipatory anxiety (Quotes 3 
and 4, Table 2). For some, this perceived suddenness led to feelings of “shock” and a 
desire to deny the prospect of admission (Quotes 5 and 6, Table 2). For one parent, 
the news that her daughter was to be admitted was perceived as altogether 
“overwhelming”, affecting her ability to retain important information about the 









‘Going in blind’  
 
Although the shock of admission may have impacted upon their ability to take on 
board what was said, parents unanimously reported that they received minimal 
preparatory information. For one parent, it felt as if she was “going in completely 
blind” (Quote 8, Table 2). 
 
Parents noted that information provided was primarily medical and practical in 
nature with no exploration of the psychosocial implications (Quotes 9 and 10, Table 
2). Some parents highlighted that although medical procedures were broached; 
information regarding outcomes, associated risks and possible side effects of the 
medication were not discussed, leaving them feeling out of control of their child’s 
long-term well-being (Quotes 11 and 12, Table 2). 
 
Parents highlighted the importance of providing adequate preparatory information. 
They reported a need for detailed information regarding the management of their 
child’s condition (treatment, mechanisms of drug action and potential side effects) 
and the expected treatment outcomes. Furthermore, parents acknowledged a need for 
information regarding the psychological impact of admission (Quotes 13 and 14, 
Table 2). 
 
Theme 2. The ward as a challenging environment 
 
As a consequence of the limited preparatory information, parents reported feeling ill-
prepared for the changes in routine, the sense of isolation and the intensity of the 
ward setting. As previously noted, CF is a condition that requires a structured 
treatment regimen for effective disease management; parents therefore play a key 
role in maintaining adherence (Modi, Marciel, Slater, Drotar, & Quittner, 2008). 
Some parents reported difficulty adjusting to changes in routine, noting the “fluid” 
nature of the ward environment and associated lack of structure regarding 
medication and treatment delivery (Quotes 15 and 16, Table 2).  
 
 




The privacy afforded by individual rooms was valued by some, as it allowed for an 
element of environmental control to be regained (Quote 17, Table 2). However, for 
others, this segregation evoked intense feelings of “isolation”, particularly for 
parents of younger children (Quote 18, Table 2). Although parents acknowledged the 
importance of segregation measures in reducing the chances of cross-infection, some 
perceived these measures as punitive. One parent, whose child was 20 months at the 
time of admission, compared the room to a “prison cell” in which she felt “trapped”. 
 
The ward environment was described as “light” and “noisy”, with frequent 
disruptions taking place throughout the night. These environmental factors were 
associated with feelings of exhaustion (Quotes 19 and 20, Table 2). 
 
Some parents spoke of the emotional impact of being on the ward and the difficulty 
in seeing sick and vulnerable children. One parent spoke of her distress in seeing an 
older child with CF, which aroused her own fears regarding the future (Quote 21, 
Table 2). These feelings were echoed by another parent who described the ward 
experience as a “reality check” raising awareness to the fact that her child had a 
serious chronic condition that could result in multiple hospital admissions. 
 
A couple of parents recommended a pre-admission visit to the ward in order to build 
familiarity with the setting and therefore decrease anxiety (Quotes 22 and 23, Table 
2). 
 
Theme 3. Changes in the parent-professional relationship 
 
Admission to the ward brought with it not only a change in environment and routine 
but also a change in staff team. As with other aspects of the admission, parents 
reported feeling unprepared for this change (Quotes 24 and 25, Table 2). Parents 
reported a trusting and supportive relationship with their community CF team, 
having known them since their child’s diagnosis; one parent referred to them as 
“family” (Quote 26, Table 2).  
 
 




This contrasted with the less individualised approach to care on the ward, with some 
parents feeling that senior professionals did not listen to them (Quote 27, Table 2), 
provide clear information regarding their child’s treatment status (Quote 28, Table 2) 
or fully appreciate their anxieties regarding their child’s admission (Quote 29, Table 
2).  
The need for more open and honest communication between senior physicians and 
parents in allaying anxiety and fostering trust was raised in several interviews. Also 
identified was the importance of informing parents of the changes in staff teams 
prior to admission (Quote 30, Table 2). 
 
Theme 4. The parental role in medical care 
 
All parents spoke of their need for involvement and participation in care. This theme 
describes the juxtaposition between two parental roles: active participant and passive 
observer. Lack of preparation and poor communication with senior ward staff left 
parents feeling disempowered and unsure of their role in care. For most parents, 
feeling in control was important; they perceived themselves as experts in their 
child’s care and thus wanted to maintain a sense of “autonomy” (Quotes 31 and 32, 
Table 2). 
 
For some parents, feeling as though they had to relinquish control to the medical 
team was perceived as frustrating (Quotes 33 and 34, Table 2). For others, a lack of 
clarity regarding their role on the ward led them to believe that their role was now 
redundant (Quotes 35 and 36, Table 2). 
The ability to regain control came more easily to some than others. One parent found 
that communication and knowledge of the situation was fundamental in bringing her 
round to hospital life (Quote 37, Table 2). For another parent, learning to administer 
IV antibiotics and working closely with the staff team allowed her to take back some 
responsibility (Quote 38, Table 2). For one parent, however, taking “a step back for a 
little while” was seen as the appropriate response (Quote 39, Table 2).  
 




Given their lack of preparation, most parents reported a desire for further 
information and knowledge. One parent spoke of her stress in not knowing (Quote 




Hospital admission can be a daunting prospect for patients and their families (Litke, 
Pikulska, & Wegner, 2012). Current health policy promotes the need to inform 
parents of what to expect during their child’s hospitalisation in order to allay fears 
and increase active participation in care (Department of Health, 2003). The findings 
of this research indicate that the majority of parents felt unprepared for their child’s 
hospital admission; specifically, they reported a short time frame between being 
notified of admission and entering the ward. Furthermore, information was 
considered limited, addressing certain practical and medical aspects of admission, 
with minimal emphasis on the psychological and social implications.  
Parents reported how inadequate preparation had an adverse impact on how they 
experienced their time on the ward. They reported feeling ill-prepared for the 
changes in the environment, routine, and staff team, resulting in anxiety, uncertainty 
and distress regarding their role in care. These findings support previous research 
that indicates hospital-related distress among parents of hospitalised children, 
especially during times of significant uncertainty (Kassam-Adams et al., 2009). 
Parental distress has been identified as a barrier to effective participation (Power & 
Franck, 2008) and has shown to impact negatively on the hospitalised child (Alisic et 
al., 2011; Dunn et al., 2012; Kassam-Adams et al., 2009; Nugent et al., 2007).   
Evidence has shown that in such situations parents will often seek to reduce their 
anxieties by improving their knowledge of their child’s treatment and negotiating 
new roles in care (Corlett & Twycross, 2006). For some parents in this study, forging 
new relationships with staff and actively seeking out opportunities to facilitate in 
care led to a positive hospital experience. For most, however, a lack of effective 
parent-professional communication and clearly articulated expectations from 
medical staff limited parents’ capacity to participate actively in care. These findings 
 




highlight some of the challenges associated with implementing a ‘family-centred 
care’ approach within routine clinical practice. 
Consistent with previous research, parents reported that they would have appreciated 
timely, detailed and comprehensive information, addressing the full range of 
medical, practical and psychosocial implications of admission. In so doing, parents 
felt that they would be better equipped to cope with their child’s hospitalisation, 
adjusting their expectations accordingly and effectively preparing for admission 
(Chapados, Pineault, Tourigny, & Vandal, 2002; Conway et al., 2006; Franck & 
Spencer, 2005). Indeed, parental satisfaction with their child’s medical care has been 
found to be closely associated with their perception of adequacy of information 
provided (Magaret, Clark, Warden, Magnusson, & Hedges, 2002). Melnyk (1994) 
utilised a randomised controlled design to investigate the usefulness of pre-
hospitalisation information in reducing parental anxiety and improving parental 
participation in care. Findings indicated that parents who received information about 
their child’s expected behaviour and their own optimal role in care (intervention 
group) were significantly less anxious during their child’s hospitalisation and were 
more supportive in care than parents who did not receive this information (control 
group).  
 
Implications for clinical practice 
 
This study provides a valuable insight into parent’s experiences of their child’s initial 
hospital admission and has important implications for clinical practice. A key 
message arising from the interviews was the parents need to be perceived as joint 
advocates with clinicians for their child’s care, comfort and improved health. This 
fits with their perceived role as both ‘parent’ and ‘carer’ for their child, having 
developed expertise in the management of their child’s condition (Modi et al., 1998). 
Health care professionals have a role in assisting parents make informed decisions 
and to retain a sense of control over their child’s treatment. In order to facilitate this, 
there is a need for parents to have access to sufficient preparatory information prior 
to admission (e.g., in the form of a leaflet or DVD) and to have the freedom to 
openly discuss their concerns regarding their child’s healthcare during the hospital 
 




stay (Appendices D reports specific recommendations for clinicians within the 




This study has several limitations. A small sample size limits the generalisability of 
the themes and therefore service changes must be considered with some caution.  
Eleven of the twelve parents interviewed were White British; therefore issues 
relating to culture and ethnicity that may have affected parental experiences were not 
explored. A common critique of studies regarding parental experiences is the lack of 
fathers’ views (Noyes, 1998). While the aim of the present study was to gain a 
general understanding of parents’ concerns, no attempts were made to have an equal 
number of fathers and mothers. Two fathers were present during the interviews; 
however they contributed minimally to discussion, perhaps primarily because they 
reported having not stayed with their child during the hospitalisation. Conducting 
interviews with each parent separately may have helped overcome this issue. 
 
While this study highlights parent perspectives of service delivery, the authors 
recognise that these can differ from clinician perspectives. For example, inadequate 
resources (e.g., low staff to patient ratio) can hinder clinicians’ efforts in providing 
supportive services. Health care professionals could demonstrate an understanding of 
the plight of parents who may feel disempowered, ill-informed and strained by 




The findings of this study indicate the importance of adequate preparatory 
information in reducing parental stress and influencing how future experiences are 
appraised and managed. Information must address all aspects of admission including 
the medical, practical and psychosocial implications. Effective parent-professional 
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Background: Parkinson’s Disease (PD) is neurodegenerative condition with an 
unpredictable prognosis. Although research indicates high levels of anxiety and 
depression among those with PD, few studies have focussed on more specific 
psychological factors such as anxiety focussed on health. Objective:  The primary 
aim of this study was to evaluate the extent and impact of health anxiety on quality 
of life (QoL), psychological distress and perceived disability in patients with PD.  
Method: Fifty-five patients with PD completed questionnaires assessing health 
anxiety, mood, and QoL. Participants also completed tasks assessing cognitive and 
physical functioning and perceived performance. Participants with relatively high or 
relatively low health anxiety were compared with a non-PD community sample 
(N=32). Results: The high health anxiety PD group reported significantly lower 
QoL relative to both comparison groups independent of level of disability. They also 
reported elevated psychological distress (anxiety and depression). The PD groups 
were significantly impaired on both cognitive and physical endurance tasks relative 
to healthy controls, but only the high health anxious PD group perceived themselves 
as significantly impaired on the cognitive task. Neither PD group perceived their 
performance as impaired on the physical task. Health anxiety was found to be a 
better predictor of psychological distress relative to other contributory factors such 
as intolerance of uncertainty. Conclusion: Health anxiety may interact with the 
experience of PD in ways which impact on QoL, psychological distress and 
perceived disability. PD patients may also underestimate the impact of their illness 
on their physical impairment.  
 
Keywords: Parkinson’s disease; health anxiety; intolerance of uncertainty; 













Parkinson’s Disease (PD) is a chronic neurodegenerative condition affecting 
approximately 127,000 people in the United Kingdom (Parkinson’s UK, 2015). It is 
characterised by the profound and selective loss of dopaminergic neurons in the 
substantia nigra. As the disease progresses, increasing neuronal dysfunction affects 
the central, peripheral, and automatic nervous system resulting in more widespread 
impairment (Jellinger, 2012). Cardinal features of PD include resting tremor, 
slowness of movement, rigidity and postural instability (Jankovic, 2008). Non-motor 
symptoms are also present in those with PD, often predating the onset of motor 
symptoms and worsening with disease progression (Chaudhuri, Healy, & Schapira, 
2006). These include psychological problems, cardiovascular and gastrointestinal 
difficulties, sleep disturbances and cognitive decline (Park & Stacy, 2009).  
 
Although effective motor symptomatic control is possible with medical treatment in 
the early-to-mid stages, the majority of patients experience motor fluctuations 
(referred to as ‘on-off’ states) and increasing disability as the disease progresses, 
resulting in a gradual deterioration in health and cognitive status (Lang & Lees, 
2002). A diagnosis of PD therefore represents the prospect of diminishing ability to 
perform basic daily activities, increased dependency and decreased predictability 
regarding ones symptoms and the future. Not surprisingly therefore, PD is a 
distressing and anxiety provoking condition for both patients and their carers (Peters, 
Fitzpatrick, Doll, Playford, & Jenkinson, 2011). 
 
Parkinson’s Disease and psychological symptoms 
 
Clinically, psychological difficulties are one of the most commonly reported non-
motor symptoms of PD (Gallagher, Lees, & Schrag, 2010). Studies have indicated a 
higher prevalence of anxiety and depression in patients with PD compared to healthy 
age-matched controls (Chaudhuri et al., 2006) and individuals with other chronic 
conditions (Pincus & Tucker, 2003). It is estimated that depression affects 35% of all 
PD patients (Reijnders, Ehrt, Weber, Aarsland, & Leentjens, 2008) and up to 43% of 
patients suffer from a circumscribed anxiety disorder (Dissanayaka et al., 2010; 
 




Leentjens et al., 2011; Menza, Robertson-Hoffman, & Bonapace, 1993; Pontone et 
al., 2009; Richard, 2005).  
 
Psychological symptoms in PD have been found to have a negative effect on QoL 
(Carod‐Artal, Vargas, & Martinez‐Martin, 2007; Pachana et al., 2013; Schrag, 2006), 
cognitive functioning (Bogdanova & Cronin-Golomb, 2011; Norman, Tröster, 
Fields, & Brooks, 2014; Ryder et al., 2002), and existing motor symptoms (Chen & 
Marsh, 2013).  
 
In general, it is argued that the increased prevalence of psychological symptoms in 
PD may be a consequence of interactions between (a) the neurodegeneration of 
neurochemical pathways involved in the regulation of mood and anxiety and (b) the 
psychological response to the physical symptoms and adverse effects of the disease 
(Dissanayaka et al., 2010). Given the distress associated with a diagnosis of PD and 
the unpredictability of disease outcome over time, researchers have argued that 
psychological factors may play a significant role in the emotional distress 
experienced by patients with PD (e.g., Burn et al., 2012; Quelhas & Costa, 2008). 
However, despite recent research focussing on the prevalence of anxiety and 
depression in PD (e.g., Pontone et al., 2009; Richard, 2005; Reijnders et al., 2008), 
few studies have focussed on the specific psychological factors and processes that 
may underpin emotional distress and psychological well-being in these patients 
(Dissanayaka, 2010).  
 
Psychological mechanisms in Parkinson’s Disease 
 
Given the unpredictable and degenerative nature of PD, it is likely that some patients 
will experience significant concerns about their health. Anxiety about health can be 
represented as a continuum, with minimal concern or absence of preoccupation with 
bodily symptoms at one end and extreme anxiety about one’s health on the other 
(Warwick & Salkovskis, 1990). According to the cognitive behavioural model 
(Warwick & Salkovskis, 1990), health anxiety arises from a tendency to believe that 
perceived bodily variations are due to health problems which are more serious than 
is actually the case. This tendency is maintained by a series of processes 
 




characterised by vicious circles which can include increased attention both to the 
body and medically relevant information and safety seeking behaviours such as 
excessive reassurance seeking. These can all reinforce the misinterpretation of 
perceived bodily variations, leading to further anxiety. 
 
Although this model was developed for people without diagnosable disease but who 
do report health anxiety, there is some evidence that health anxiety is experienced by 
individuals with ongoing and unpredictable illness. Research has shown that 
individuals with heart disease, who had previously experienced heart attacks and 
scored highly on health anxiety measures, were more likely to think that common 
bodily sensations were due to their disease, compared to their counterparts without 
health anxiety (known as misattribution; Ratcliffe, MacLeod, & Sensky, 2006). 
Similarly, patients with upper respiratory tract infection and greater psychological 
distress paid closer attention to their bodily sensations (known as amplification; 
Barsky, Goodson, Lane, & Cleary, 1988).  
 
Recent research has raised the possibility that similar mechanisms may occur among 
individuals with neurological conditions. Hayter, Salkovskis, Morris, and Silber (in 
press) investigated the prevalence of health anxiety among patients with relapsing-
remitting multiple sclerosis (RRMS), a neurodegenerative disease with an 
unpredictable prognosis. The authors examined factors maintaining health anxiety in 
this population and the impact on self-reported QoL. Findings indicated that higher 
levels of health anxiety were associated with lower QoL scores and a tendency to 
attribute common bodily symptoms to disease factors. Further, when asked to 
complete a series of cognitive and physical endurance tasks, those with higher levels 
of health anxiety were more likely to perceive their performance negatively, 
attributing difficulty to their disease. These findings have been supported by a recent 
replication study (Carrigan, unpublished doctoral dissertation). 
 
Similarly to patients with relapsing and remitting MS, patients with PD may 
experience their symptoms as unpredictable and threatening and therefore have an 
inclination to monitor their bodies and behaviour for possible signs of illness. This 
may lead to preoccupation and distress when such signs are detected. However, no 
 




studies have investigated whether this understandable worry is severe enough to 
satisfy the criteria for health anxiety. If it is the case that patients with PD display 
high levels of health anxiety it would be interesting to investigate the impact on 
psychological well-being and QoL and explore potential maintenance factors.  
 
The present study will also examine the relative contribution of healthy anxiety and 
intolerance of uncertainty (IoU; Dugas, Freeston, & Ladouceur, 1997) in predicting 
patient distress. IoU is a factor known to be associated with generalised anxiety and 
that might be relevant in predicting distress in patients with PD. IoU has shown to 
increase perceived stress and lead to poorer emotional wellbeing in cancer patients 




The aims of the present study are as follows: (i) to measure the extent of health 
anxiety in a sample of patients with early to mid-stage PD, (ii) to evaluate whether 
health anxiety adversely impacts QoL, even when controlling for level of disability, 
(iii) to evaluate whether health anxiety adversely impacts patient reported 
psychological distress (anxiety and depression), (iv) to evaluate the impact of health 
anxiety on perceived impairment of cognitive and physical performance and (v) to 
examine the relative contribution of psychological factors (health anxiety and IoU) 






The main group comparison was between PD patients with relatively high or 
relatively low health anxiety. A healthy community sample (of similar age and 
gender) was recruited in order to benchmark the two group comparisons. Predictors 









Hayter et al. (in press) found a large effect size (1.1) in RRMS patients, utilising a 
total sample size of 42 (21 participants per group). Assuming similar but smaller 
effects in PD, the power analysis conducted using G* Power indicated that with a 
large effect size (0.8) and an alpha level of 0.05, 52 PD patients (26 per group) 




Forty-eight patients were recruited from Movement Disorder and Neurology out-
patient clinics in the South West of England (Bath and Swindon) and a further ten 
patients were recruited through Parkinson’s UK (registered charity). All patients 
were diagnosed with idiopathic PD by movement disorder specialists, according to 
the United Kingdom Brain Bank criteria. Participants were over the age of 18 years 
and had a mild to moderate level of disability as defined by a score of <2.5 on the 
Hoehn and Yahr Scale (Hoehn & Yahr, 1967, as cited in Goetz et al., 2004). Patients 
were excluded from the study if they met any of the following criteria: (a) score of 
<22 on the Montreal Cognitive Assessment (MoCA; Nasreddine, 2005) (indicating 
significant cognitive impairment) (b) history of secondary or atypical Parkinsonism, 
(c) presence of a complex/severe mental health problem or (d) evidence of co-
morbid acquired brain injury. Three patients were excluded on the basis of exclusion 
criteria (a), leaving a total sample of 55 participants. Thirty-two healthy control 
participants were recruited into the study using a research advertisement distributed 
within community settings (e.g., local social clubs). Written informed consent was 
















Disability and disease severity 
 
Movement Disorder Society Unified Parkinson’s disease Rating Scale Part II (MDS-
UPDRS; Goetz et al., 2007). The MDS-UPDRS is a patient rated measure of PD 
motor symptoms. Higher scores indicate greater disability. The MDS-UPDRS has 
good psychometric properties (Goetz et al., 2008).  
 
Hoehn and Yahr Scale (HY; Hoehn & Yahr, 1967, as cited in Goetz et al., 2004). 
The HY is a standard clinical index of PD motor stage. It globally indexes signs and 
symptoms of functional impairment, including postural instability, rigidity, tremor, 
and bradykinesia. The HY has demonstrated moderate to significant levels of inter-




Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). The 
HADS is a 14-item self-report measure of anxiety and depression. Subscale scores 
can be computed for depression and anxiety, scores of 8-10 indicate ‘possible’ 
depression or anxiety, and >11 a ‘definite’ problem. The HADS has been validated 
for use in PD (Mondolo et al., 2006; Rodriguez‐Blazquez, Frades‐Payo, Forjaz, de 




Short Health Anxiety Inventory (SHAI; Salkovskis et al., 2002). The SHAI is a 14-
item measure of health-related anxiety. Participants choose one of four statements 
for each item which relates best to their health related thoughts and behaviours. A 
cut-off score of 18 or greater indicates clinical levels of health anxiety (Seivewright 
et al., 2004), a score of 15 suggests symptoms of health anxiety. The SHAI has good 
reliability and validity (Salkovskis, Rimes, Warwick, & Clark, 2002). The SHAI was 
modified for PD with the author’s permission. This involved adding ‘‘other than 
 




PD,’’ to items 5, 9, 11, and 12 so that participants’ responses were not limited by 
already having a serious health condition (e.g., ‘‘as a rule, I am not afraid that I have 
a serious illness [other than PD]’’).   
 
Intolerance of uncertainty 
 
Intolerance of Uncertainty Scale Short Form (IUS-12; Carleton, Norton, & 
Asmundson, 2007). The IUS-12 is a 12-item measure. Items are scored on a 5 point 
Likert scale ranging from 1 (not at all characteristic of me) to 5 (entirely 
characteristic of me), higher scores reflect higher levels of IoU. The IUS-12 has 
shown to have excellent internal consistency and convergent validity with the 
original version (Carleton, Norton, & Asmundson, 2007). 
 
Quality of life 
 
Ferrans and Powers Quality of Life Index (QLI; Ferrans & Powers, 1992). The QLI 
is a 37-item self-report measure that assesses an individual’s satisfaction with 
various domains of life, taking into account their relative importance to the 
respondent.  Items are rated on a 6 point Likert scale (1 = very dissatisfied to 6= very 
satisfied), scores range from 0-30. Higher scores reflect higher levels of QoL.  The 
QLI has been used in studies of various physical health conditions, and possesses 




Executive function deficits are observed in PD patients even relatively early on in 
the disease process (Emre, 2003).The Brixton Spatial Anticipation Test (BSAT; 
Burgess & Shallice, 1997) was used as a measure of executive functioning. This task 
is designed to measure rule attainment, flexibility of thinking and appropriate 
switching of behaviour. The BSAT is a valid and reliable measure which is widely 
used in the general and PD population to indicate difficulty with planning and 
following rules.  
 
 






A hand grip dynamometer was used to measure hand strength and endurance. The 
protocol for using the hand grip dynamometer  followed that used by Hayter et al. (in 
press) and is based on that used in a study investigating people with chronic pain 
(Rode, Salkovskis, & Jack, 2001). The hand grip task has been used in the literature 
to measure hand strength in patients with PD (e.g., Roberts, Syddall, Butchart, Stack, 
Cooper, & Sayer, 2015). 
 
Misperception and Misattribution of task performance 
 
Misperception of performance on the cognitive and physical tasks was assessed 
using a similar measure to the one developed in the Hayter et al. study (in press). 
Following the physical and cognitive tasks, participants were asked to evaluate how 
well they felt they had performed compared to individuals in the general population 
on a scale from -50 (“extremely badly in comparison to others”) to +50 (“extremely 
well in comparison to others”). They then completed a measure of how worried they 
were about their performance  0 (“not worried at all”) to 100 (“extremely worried”) 
and how much better they felt their performance on the tasks would have been if 





Clinicians identified eligible participants from their caseload. Within routine clinic 
appointments or during home visits, eligible participants were invited to take part in 
the research. It was made clear that individuals were under no obligation to 
participate and that they could withdraw at any time.  
 
Once written informed consent was obtained, participants were contacted by 
telephone by the lead researcher to arrange a formal research session. Participants 
were free to choose whether this session took place within their own home or at one 
of the allocated outpatient clinics. Prior to the formal research session, participants 
 




were sent a questionnaire pack to complete. During the research session, participants 
completed the assessment of physical and cognitive functioning before completing 
subjective ratings of their performance. The session took approximately 1 hour. The 




Ethical approval for the study was obtained from the Wales NHS Research Ethics 
Committee (ref: 14/WA/0193) and the University of Bath’s Department of 




Statistical analysis was performed using SPSS for Windows 21. High health anxious 
(HiHA), low health anxious (LowHA) and healthy control (HC) groups were 
compared using ANOVAs (with ANCOVAs where appropriate) for three group 
analyses. Where within subjects elements were included in analyses, mixed model 
ANOVAs were used, with simple main effects analyses used to interpret interactions 
when present. The alpha level was set at .05 for statistical significance for all tests. 
Multiple comparisons used Least Significant-Difference (LSD), except when 
Levene’s test for homogeneity of variance was significant, in which case Dunnett’s 
T3 test was used. For categorical variables, chi-squared analyses were used to 
determine whether there were statistically significant differences between groups (α 
= .05).  
 
Linear step-wise regression analysis was carried out to examine predictors of patient 
psychological distress (anxiety and depression) for the entire PD sample. IoU, SHAI, 
and UPDRS Part II total scores, age, MoCA and Hoehn and Yahr scores were used 










Sample characteristics  
The PD sample consisted of 27 males (49%) and 28 females (51%) with a mean age 
of 66.6 years (range = 38-86, SD=8.45). All participants identified themselves as 
White British. Patients had a median Hoehn & Yahr score of 1.5 (range = 1.0-2.5). 
The average duration of PD was 3.45 years (range = 0.5-18 years, SD=3.61) (see 
Table 1). Eighty percent of the sample was using Levodopa, and 55% were also 
receiving adjunctive anti-Parkinsonian medications, including dopamine receptor 
agonists, MAO-B inhibitors and COMT inhibitors. Nine percent of patients were on 
no anti-parkinsonian medication.  
The total PD sample had a mean score of 11.82 (SD = 5.74) on the Short-Health 
Anxiety Inventory (SHAI). For the main analysis, high health anxiety (HiHA) was 
defined as a score of 14 or greater; low health anxiety (LowHA) was defined as a 
score of 12 or less. These cut-off values were based on a median split of the data 
with the middle two values removed. This allowed for reasonable confidence in the 
group separation (SE = 0.55).  This method was used in place of using clinical cut-
off values for the SHAI as too few participants fell in the high health anxiety range. 
 
This meant that for group comparisons, the HiHA group comprised of 21 PD 
patients, and the LowHA group comprised of 32 PD patients. For other analyses, the 
two participants that fell between these two zones were included. Thirty-two healthy 
controls had a mean score of 9.41 (SD = 4.46) on the SHAI.  
 
As can be seen in Table 1, the HiHA, LowHA, HC groups showed no statistically 
significant differences in age (F (2, 84) = 1.71, p, p>.05), gender (χ² (2) = .573, p>.05), 
or scores on the cognitive screen (MoCA) (F (2, 84) = 1.27, p>.05). Groups did differ 
significantly in terms of the number of years spent in formal education (F (2, 84) = 
7.22, p, p<.05). Multiple comparisons indicate that both PD groups spent less years 
in formal education compared to the HC group (p<.01). HiHA and LowHA did not 
differ significantly from one another (p>.05). The samples were comparable in terms 
of demographics, with the exception of the control group who spent more years in 
formal education. 
 




Table 1. Means (SDs) of sample characteristics, PD-related variables and scores on questionnaire measures 
 PD (LowHA) (N=32) PD (HiHA) (N=21) HC  (N=32) 
Sample characteristics Mean (SD) Mean (SD) Mean (SD) 
Age 67.34 (9.92) 65.90 (6.05) 63.78 (6.07) 
Gender 53.1% male,  
46.9% female 
42.9% male,  
57.1%female 
46.9% male,  
53.1% female 







MoCA score 27.06 (2.18) 26.71 (1.85) 27.56 (1.76) 
PD-related variables    
Hoehn & Yahr Scale Score 1.66 (0.48) 1.86 (0.50)  
UPDRS Part II 9.66 (7.48) 11.71 (6.38)  
Years since diagnosis  2.96 (2.79) 3.52 (3.48)  




  (4.38)  











































Note: Means sharing a subscript are not significantly different from each other (p > .05). Means sharing dissimilar 
subscripts differ significantly (ps < .05). 





PD-related variables  
 
As can be seen in Table 1, the two PD groups (HiHA and LowHA) showed no 
statistically significant differences in time since diagnosis (F (1, 52) = .42, p>.05), 
disability status (F (1, 52) = 1.08, p>.05; measured on UPDRS Part II) or disease stage 
(F (1, 52) = 2.12, p>.05; measured using the Hoehn and Yahr Scale). There were 
significant differences in reported years since symptom onset (F (1, 52) = 6.37, p<.05). 
The two groups were comparable, with the exception that the HiHA group reported a 




Quality of life 
 
In the first analysis, PD participants were compared with healthy controls on QoL, as 
measured by the QLI. In a one-way ANOVA there was a significant main effect of 
group on QLI scores, F (1, 86) =11.70, p<.001, with PD participants having lower 
scores overall. The three group comparison (HiHA, LowHA and HC) also showed a 
significant main effect of group, F (2, 84) = 15.24, p<.0001. Multiple comparisons 
indicate that impaired QoL was confined to the HiHA group, who reported 
significantly lower QoL than the LowHA group (p<.0001) and the HC (p<.0001), 
who did not significantly differ (p>.05) (see Table 1). 
 
An ANCOVA was carried out comparing the HiHA and LowHA PD groups, 
covarying for level of disability (as measured by Part II of UPDRS). This showed a 
main effect of group; F (1, 50) = 17.41, p<0.001. Adjusted QoL means for high and 
low health anxiety groups were 17.75 and 21.83 respectively. As the UPDRS Part II 
is a self-report measure a further covariance analysis was conducted, this time using 
the Hoehn and Yahr score, a clinician rated measure of disability. This analysis 
showed a mean effect of group; F (1, 50) = 14.20, p<.0001. Adjusted QoL means for 
high and low health anxiety were 17.49 and 22.01 respectively.  
 
 







In the second main analysis, the three groups (HiHA, LowHA and HC) were 
compared on levels of psychological distress, as measured by the HADSA and 
HADSD. This analysis utilised a 2 (HADSA, HADSD) by 3 (HiHA, LowHA, HC) 
mixed model ANOVA revealing a significant effect of subscale F (1, 82) = 47.97, 
p<.0001 and of group F (2, 82) = 15.97, p<.0001, with the group by subscale 
interaction not significant (F<1). Regardless of group, HADSA was significantly 
higher than HADSD. In order to evaluate the group effect, a further one-way 
ANOVA was carried out on HADS total; F (2, 84) = 15.97, p<.0001. Multiple 
comparisons indicate that the HiHA reported significantly higher HADS total scores 
compared to the LowHA group (p<.0001) and the HC group (p<.0001); who did not 
significantly differ (p>.05) (see Table 1). 
 
Cognitive and physical tasks  
 
Objective performance on cognitive and physical tasks 
Actual performance on the cognitive and physical tasks were first analysed in order 
to determine degree of impairment. A one-way ANOVA comparing all three groups 
on the Brixton showed a significant main effect of group, F (2, 84) = 10.78, p<.0001. 
Multiple comparisons indicated that both LowHA and HiHA groups were impaired 
compared to HC (p<.05) and did not differ from each other (p>.05). 
 
A one-way ANOVA comparing all three groups on the Hand Grip Endurance Task 
showed a significant main effect of group, F (2, 84) = 7.16, p<.001. Multiple 
comparisons indicated that both LowHA and HiHA groups were impaired compared 
to HC (p<.05). The HiHA and LowHA groups were not significantly different to 
each other (p>.05). These results indicate similar levels of impairment in both PD 
groups relative to controls on both tasks (see Table 2). 
 
 





Table 2. Mean (SD) scores for the cognitive and physical tasks across groups 























Note: Means sharing a subscript are not significantly different from each other (p > 
.05). Means sharing dissimilar subscripts differ significantly (ps < .05) 
 
Perceived performance on cognitive and physical tasks 
Having established comparability on actual task performance, perceived 
performance was then analysed. A 3 (HiHA, LowHA, HC) by 2 (performance 
ratings on Brixton, Hand Grip Endurance Tasks) mixed model ANOVA revealed 
that there was a significant main effect of group on perceived task performance; F (2, 
82) =3.22, p<.05. There was also a significant main effect of task type on perceived 
task performance; F (1, 82) =6.94, p=.01. The interaction between group and task type 
was not significant; F (2, 82) =1.74, p=.18. Multiple comparisions across performance 
ratings (Brixton and Hand Grip Endurance Task) revealed a significant difference 
between the HiHA PD group and HC (p<.05), with no other multiple comparisions 
being significant.  
 
A supplementary simple main effects analysis indicated a significant main effect of 
group on perceived task performance on the Brixton, F (2, 84) = 3.50, p<.05; multiple 
comparisons indicated that the HiHA group reporting poorer performance relative to 
the HC group (p<.05) but not the LowHA group, which also did not differ from the 
HC (p>.05) (see Table 3). By contrast, a one-way ANOVA failed to reveal a 
significant main effect of group on perceived task performance on the Hand Grip 
Endurance Task, F(2,84) = .99, p>.05. 
 
A 3 (HiHA, LowHA, HC) by 2 (worry over performance ratings on Brixton, Hand 
Grip Endurance Tasks) mixed model ANOVA revealed that there was a significant 




main effect of group on perceived worry regarding task performance; F (2, 82) = 6.75, 
p<.05 . There was also a significant main effect of task type on perceived worry over 
task performance; F (1, 82) = 47.82, p<.0001. The interaction between group and task 
type was not significant; F (2, 82) = .92, p>.05. Multiple comparisions across 
performance ratings (Brixton and Hand Grip Endurance Task) revealed a significant 
difference between the HiHA PD group and HC, (p<.001), and between the low HA 
PD group and HC (p<.05). There was no difference between HiHA and LowHA 
groups. Further, an independent groups t-test revealed no significant difference 
between the two PD groups on how much better they thought they would have 
performed on the Brixton had they not had PD (t(51) = -1.27, p>.05, two-tailed; Table 
3). 
 
Table 3. Participants’ subjective ratings (Mean and SD) of their performance on the 
cognitive and physical tasks  
 





Cognitive task    
Perceived performance  
(-50 to+50) 
-4.06






Worry about performance 









if no PD 
(0 to 100) 
29.38 (30.15) 39.52 (25.39) NA 
Physical task    
Perceived performance  
(-50 to +50) 
8.75 (17.55) 1.90 (18.06) 6.25 (16.61) 
Worry about performance  
(0 to 100) 
13.13 (18.22) 19.52 (20.37) 5.63 (12.68) 
Performance on 
improvement if no PD  
(0 to 100) 
30.31 (27.88) 45.71 (31.71) NA 
Note: Means sharing a subscript are not significantly different from each other (p > 












Stepwise regression analyses allowing all predictors to compete for variance 
 
In order to evaluate the relative contribution of psychological factors (health anxiety 
and IoU) and other variables of interest in predicting psychological distress across 
the entire PD group, a stepwise linear regression analysis was used. Collinearity 
statistics and diagnostics were conducted. None of these analyses suggested that 
multicollinearity was a cause for concern. IoU, SHAI and UPDRS Part II total 
scores, age, MoCA and Hoehn and Yahr scores were used as predictor variables and 
the HADS total score was used as the dependant variable. The first variable to enter 
was HAI total, accounting for 43% of the variance in scores on the HADS 
(adjusted R
2
 = 0.43, β = 0.66, P = < 0.001). The second variable entered was the 
UPDRS Part II total (adjusted R
2
 = .57, β = .40, P = < 0.001). The R2 change 
attributable to the UPDRS was .15. The third and final variable entered was IoU total 
(adjusted R
2
 = .61, β = .24, p=.02). The R2 change attributable to the IoU was .04. 
The three variables together had an adjusted R
2
 of .61 (see Table 4).  
 
Table 4. Stepwise regression results for variables predicting psychological distress 
 B SE B β 
Step 1     
Constant 2.84 1.50  
SHAI Total 0.73 0.11 .66*** 
Step 2    
Constant 0.58 1.40  
SHAI Total 0.62 0.10 .56*** 
UPDRS Part II Total 0.34 0.08 .40*** 
Step 3    
Constant -2.18 1.75  
SHAI Total 0.51 0.11 .46*** 
UPDRS Part II Total 0.30 0.08 .36*** 
IoU Total 0.17 0.07 .24* 
Note: R
2
 = .43 for Step 1(p<.0001); Δ R2 = .15 for Step 2(p<.0001); Δ R2 = .04 for 
Step 3 (p<.05) * p<.05, **p<.01, ***p<.0001 
 






This study evaluated the extent of health anxiety in a sample of patients with PD and 
examined the impact of health anxiety on QoL, psychological distress and perceived 
task performance.  
  
Results indicated that overall, patients with PD experienced significantly greater 
levels of health anxiety than healthy controls. When the high and low health anxiety 
groups were compared, there were no differences in level of patient or clinician rated 
disability. However, the high health anxiety group reported lower QoL and greater 
psychological distress. The low and high health anxiety PD groups were similarly 
and substantially impaired on both cognitive and physical endurance tasks relative to 
healthy controls. Patients with PD and higher levels of health anxiety reported poorer 
perceived performance on the cognitive task and greater worry about their 
performance relative to healthy controls, although they did not differ significantly 
from low health anxious PD patients. Interestingly, despite their actual impairment, 
neither PD group perceived their performance on the physical task as impaired. 
When psychological factors (health anxiety and IoU) were entered into a stepwise 
regression analyses along with other potential predictors, health anxiety proved to be 
the most significant predictor of psychological distress. 
 
Given that many patients with PD eventually experience significant disability, their 
psychological distress and lower QoL is understandable. However, the extent of 
these problems was found to be related to health anxiety more than actual 
impairment. Similarly, previous studies involving PD patients have found general 
anxiety and depression to be significant predictors of QoL rather than cognitive 
status or motor stage (Hanna & Cronin-Golomb, 2012; Carod-Artal, Ziomkowski, 
Mourao, Mesquita, & Martinez-martin, 2008; Quelhas & Costa, 2008). The results 
of the present study are consistent with the primary findings of Hayter et al. (in 
press) and Carrigan (unpublished doctoral dissertation) who found that among a 
group of patients with relapsing remitting MS, higher levels of health anxiety were 
associated with significant reductions in QoL and psychological wellbeing, and that 
this effect was evident when disability status was controlled.  




In the present study, patients with high health anxiety correctly perceived their 
performance on the cognitive task as impaired relative to healthy controls, but in 
contrast to the findings of Hayter et al. (in press) both PD groups actually 
underestimated impairment on the physical task to similar levels.  
 
Consistent with the view that patients underestimated performance on the physical 
task, there is evidence to suggest that dopaminergic treatment may have an impact on 
subjective perceptions of motor function. Amanzio et al. (2010) explored the effects 
of dopaminergic medication on awareness of motor dysfunction in a sample of PD 
patients experiencing motor fluctuations. These authors found that patients showed 
reduced awareness of evident movement disorder (dykinesias) in the ‘on’ state (state 
of optimal drug efficacy), as demonstrated by a discrepancy between patient and 
professional ratings of symptom severity. Conversely, patients displayed preserved 
awareness of evident movement disorder (hypokinesias) and associated 
psychological distress, in the ‘off’ state (state of decreased drug efficacy). The 
authors hypothesised that dopaminergic treatment may have a detrimental influence 
on the function of the orbitofrontal and cingulated frontal-subcortical loops; whose 
projections appear to be critical in the awareness phenomenon (Leritz et al., 2004; 
Seltzer et al., 2001). Eighty percent of patients recruited into the present study were 
taking Levodopa. Further, patients were tested when on medication to ensure their 
optimal motor state and to minimise motor demands. It is possible therefore, that 
medication may have had an effect on perceived performance.  
 
Further, the sample comprised of patients with early to mid-stage disease: the mean 
duration of symptoms was approximately three years. Effective symptomatic control 
of motor and non-motor symptoms during the early stages of the disease is possible 
with dopaminergic medication (Lang & Lees, 2002). It is possible that, in the 
absence of objective feedback on performance and with patients perceiving 
symptoms as relatively well controlled under medication, they overestimated their 










While the number of participants recruited into the study matched that indicated in 
the initial power calculation, the sample size was still relatively small. The study 
focussed on a specific subgroup of patients with PD (those with early-to mid-stage 
disease). As a result, caution is needed when generalising these findings to the PD 
population more broadly. A further issue was how participants were allocated to 
groups. The total PD group was divided into those with SHAI scores of 14 or greater 
or 12 or less. In the study by Hayter et al. (in press), patient groups were divided into 
those meeting criteria for hypochondriasis (scoring >18) and those without evidence 
of health anxiety (scoring <10), hence there was a larger difference between the two 
groups. It is possible that other significant differences between the two PD groups 
may have been found had the disparity in health anxiety scores been greater. 
However, note that the standard error of the HAI in the PD groups was 0.55, 




Although this research indicates that health anxiety has an adverse impact on QoL 
among patients with PD, this study does not provide an indication as to the specific 
mechanisms involved in this relationship. It would be useful for future studies to 
explore the cognitive (e.g., attentional biases) and behavioural (e.g., safety seeking 
behaviours) mechanisms through which health anxiety impacts on QoL in these 
patients (see Warwick & Salkovskis, 2002).  
 
The study included self-report measures. Given potential discrepancies between 
objective and perceived performance among PD patients, future studies may wish to 
utilise alternative collection approaches, such as multiple informant measures and 
more comprehensive clinician rated measures of disability (e.g., UPDRS Part III). 
Further, future studies may wish to explore alternative measures of performance, 
potentially utilising functional every-day tasks to ensure ecological validity.  
 
Individuals in the high health anxiety group retrospectively reported having 
experienced PD symptoms for a longer duration of time. Given this information was 
self-reported it is not possible to determine whether this was indeed the case or 




whether health anxiety and associated cognitive processes (e.g., attentional biases) 
may have influenced participants’ perceptions. A prospective investigation may help 
elucidate this point further. 
 
Finally, given the potential influence of dopaminergic treatment on perceived 
performance, future studies may wish to assess patients both on and off medication. 
This could be achieved by assessing patients prior to their first daily dose of 
Levodopa. It may also be interesting to incorporate measures of movement disorder 




The findings of this study indicate that health anxiety may be a significant issue 
among patients with PD. Given the adverse impact of health anxiety on QoL and 
psychological distress, as well as the concomitant cost of health anxiety to health 
services (Tyrer et al., 2011), clinicians would benefit from routinely screening 
patients for health anxiety.  
 
The findings suggest the potential benefit of cognitive-behavioural approaches for 
treating health anxiety (CBT-HA) in those with PD. Research indicates the 
effectiveness of CBT-HA in general and there is accumulating evidence that it can 
be applied to physical health settings (Salkovskis & Warwick, 2001; Tyrer et al., 
2011). Given the presence of cognitive impairment in this group, adaptations to the 
standard CBT-HA protocol may be required. There is evidence to suggest the benefit 
of tailored cognitive-behavioural interventions for the treatment of anxiety and 
depression in patients with PD (e.g., Armento et al., 2012; Dobkin, Allen, & Menza, 
2007; Dobkin et al., 2011; Veazey, Cook, Stanley, Lai, & Kunik, 2009). The 
effectiveness of such interventions could be assessed in the first instance, using a 
consecutive single case series A–B design. A similar approach has been taken in the 
area of relapsing remitting MS (e.g., Carrigan, unpublished doctoral dissertation). 
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Parkinson’s Disease (PD) is neurodegenerative condition with an unpredictable 
prognosis, impacting on all areas of life. Although research indicates high levels of 
anxiety and depression among those with PD; few studies have focussed on more 
specific psychological factors such as anxiety focussed on health. The primary aim 
of this study was to evaluate the extent and impact of health anxiety on quality of life 




Fifty-five patients with PD took part in the study. Participants were asked to 
complete questionnaire measures assessing health anxiety, mood, and QoL. 
Participants were also asked to complete two tasks assessing cognitive and physical 
functioning with measures taken of actual and perceived performance. Participants 
with relatively high or relatively low health anxiety were identified for purpose of 
analysis. A community sample of similar age and gender (N=32), not suffering from 
PD, were recruited in order to allow comparisions to be made between patients with 




The high health anxiety PD group reported significantly lower QoL relative to both 
comparison groups, independent of level of disability. They also reported elevated 
psychological distress (anxiety and depression). The PD groups were significantly 
impaired on both cognitive and physical endurance tasks relative to healthy controls, 
but only the high health anxious PD group perceived themselves as significantly 
impaired on the cognitive task. Interestingly, neither PD group perceived their 
performance as impaired on the physical task. Health anxiety was found to be a 
better predictor of psychological distress relative to other contributory factors such 
as one’s ability to tolerate uncertain events or level of disability. 
 





Implications for research 
 
 Although this study indicates that health anxiety has an adverse impact on 
QoL among patients with PD, it does not provide an indication as to the 
specific mechanisms involved in this relationship. Future studies would 
benefit from exploring the cognitive and behavioural mechanisms through 
which health anxiety impacts on QoL in patients with PD. 
 
 Given the potential discrepancies between objective and perceived 
performance among patients with PD, future studies may wish to utilise 
alternative collection approaches, such as multiple informant measures and 
more comprehensive clinician rated measures of disability. 
 
 Future studies may wish to explore alternative measures of performance, 




 Given the adverse impact of health anxiety on QoL and psychological 
distress, as well as the concomitant cost of health anxiety to health services, 
clinicians would benefit from routinely screening for health anxiety in PD.  
 
 The findings suggest the potential benefit of cognitive-behavioural 
approaches for treating health anxiety (CBT-HA) in those with PD.  
 
 Given the presence of cognitive impairment in this group, adaptations to the 
standard CBT-HA protocol may be required. There is evidence to suggest the 
benefit of tailored cognitive-behavioural interventions for the treatment of 
anxiety and depression in patients with PD.  
 
 






Prior to training I worked primarily within the areas of adult neuropsychology and 
clinical health psychology. I have maintained my interest in these areas throughout 
my training and this is reflected in my choice of research projects. My main research 
project focusses on the area of Parkinson’s disease, whilst my literature review and 
service improvement project focus on the clinical health areas of chronic fatigue 
syndrome and cystic fibrosis.  
 
The Research Process 
Critical Review of the Literature 
My critical literature review focussed on the relationship between perfectionism and 
chronic fatigue syndrome (CFS). Prior to training I worked as an Assistant 
Psychologist within a Chronic Pain and Fatigue Management Service for one and a 
half years. During my time there, I frequently co-facilitated groups in which I would 
introduce the cognitive behavioural model of CFS (Surawy et al., 1995) and discuss 
the role of personality factors (particularly unhealthy perfectionism and achievement 
striving) as predisposing and maintaining factors of the condition. I was intrigued to 
notice that in some cases clients really responded to this explanation, noting that they 
harboured high-self standards that may have exacerbated their symptoms, whereas 
others did not relate to this at all. Further, within the service where I worked no 
specific cognitive behavioural strategies for modifying unhelpful perfectionistic 
beliefs were offered. I felt that the generation of a critical review document that 
synthesised research on this topic would be helpful for clinicians and researchers 
alike in deciding whether perfectionism was an important personality factor to target 
for intervention.  
 
Conducting the narrative review allowed me to appreciate the limited body of 
research currently focussed on the role of perfectionism in CFS, particularly studies 
using prospective or experimentally-based designs. This was indeed surprising given 
the heavy reliance on perfectionism as a suggested predisposing and maintaining 
factor in both the cognitive behavioural and psychodynamic models of CFS. I felt 
this review was therefore helpful in determining where the current research literature 




is with regard to the role of perfectionism in CFS and in highlighting potential 
avenues for future research.     
 
The literature review was one of the most challenging pieces of coursework I have 
completed so far. It required time to fully immerse myself in the research literature 
in order to critically evaluate the papers and reflect on the evidence base. Further, I 
was aware of the importance of ensuring that the method and acquisition of papers 
was conducted in a systematic fashion with clearly defined inclusion and exclusion 
criteria to help guide my search. I had helpful meetings with my course supervisor, 
Dr James Gregory and received invaluable expert input from Dr Kate Rimes, who 
has a special interest in perfectionism and CFS.  
 
Service Improvement Project  
During the first year of training, the course held a research fair. The purpose of this 
was to enable trainees to meet with local clinicians to discuss potential research 
projects. I was keen to meet with clinicians who shared my interest in clinical health 
and neuropsychology. Unfortunately, the research fair fell on a day when a regional 
clinical health network meeting was also taking place; as such it was not possible to 
meet with local clinicians directly.  
 
Instead, we were provided with the contact details of all clinicians who had 
registered an interest in conducting research. I proceeded to contact all those whose 
interests were in line with my own, with a view to finding a service that would be 
open to service improvement. Dr Samantha Phillips, from the Cystic Fibrosis Service 
at the Bristol Children’s Hospital, had supervised a trainee clinical psychologist in 
the previous cohort and wished to continue service improvement within her 
department. We met on several occasions to discuss potential research ideas. One of 
these was to follow-up on the work of the previous trainee, looking at improving 
transition arrangements from paediatric to adult services. However, when this idea 
was taken to the multi-disciplinary team (MDT) meeting it was felt that there were 
other areas that could benefit from renewed input. On reflection, earlier consultation 
with the MDT would have been helpful. This would have ensured that a team 




consensus was reached at an earlier stage, improving the overall efficiency of the 
project. 
 
I facilitated a team discussion in which we brainstormed potential ideas: At the end 
of the meeting all members agreed that a service improvement project focussing on 
the pre-hospitalisation information needs of parents of children with Cystic Fibrosis, 
would be a useful and interesting project. The team explained that at the time, 
parents were being directed to online materials which offered generic practical 
advice but did not address their psychological and social needs. Given the stress 
associated with child hospitalisation it was agreed provision of adequate resources 
was highly important. 
 
Together with the team it was agreed that the project would focus on exploring the 
experiences of parents whose children had recently been admitted for their first 
course of intravenous antibiotics. This was seen as an important admission 
experience as it was usually the first time the child had been admitted to hospital 
since infancy. It was likely that this experience would raise many fears and anxieties, 
drawing greater attention to the fact that the child had a serious chronic condition for 
which future hospital admissions could be necessary.   
 
My supervisor and I agreed that a qualitative design would be best suited to yield 
rich data and capture the reality of the parents’ experiences. Time was spent with Dr 
Phillips and the team devising stem questions that would form the topic guide for the 
semi-structured interview. I found this a really useful experience; the teams’ 
expertise yielded clear questions designed to explore parents’ feelings regarding 
existing materials and areas for service improvement. This process also allowed all 
members of the MDT to contribute to the research. Unfortunately, service users were 
not consulted during the development of the research.  
 
Recruitment into the study was relatively straightforward. Ethical approval was 
sought from both the University of Bath and the participating NHS Trust. I was 
fortunate in that the team had strong relationships with its paediatric clients and their 
families and as such we were able to recruit a good number of parents into the 
project successfully. 




Conducting the semi-structured interviews required skill in ensuring that I 
maintained an objective stance and did not influence the participants’ responses. I 
tried to be mindful of the distinction between ‘researcher’ and ‘therapist’ roles 
throughout the interview process. On reflection, more supervision or specific 
teaching on how to conduct semi-structured interviews might have been helpful.  
 
I found analysing the data and developing themes the most challenging aspect of the 
project, yet also a highly useful experience and greatly appreciated input from my 
supervisors regarding this. 
 
Following completion of the project, I was able to return to the service and feedback 
my findings; this was a very rewarding experience. The results of the project 
highlighted a number of useful recommendations for the service, which the team 
were very happy to action.  
 
Prior to training, I had only completed one qualitative piece of research. I really 
enjoyed the opportunity to conduct this qualitative study and have learnt many useful 
skills in the process.  
 
Main Research Project 
I knew from the start of training that I wanted to complete my main research project 
in the area of Clinical Neuropsychology. I met with Dr Simon Gerhand, Consultant 
Clinical Neuropsychologist in Bristol, to discuss potential ideas. Together we 
developed a project idea focussing on depressive rumination post-head injury and its 
impact on cognitive functioning and quality of life. A number of meetings were 
scheduled with Dr Gerhand and Professor Paul Salkovskis in which the idea was 
further developed. 
 
During the summer of the first year I piloted the project procedure on a number of 
patients. Dr Gerhand was very helpful in providing access to willing volunteers and 
assessment materials. I also met with a number of day centre managers from the 
brain injury charity Headway, located across Bath, Bristol and Wiltshire, to gauge 
interest.  





Unfortunately, as time progressed it became clear to me that the project would not be 
feasible within the time frame; primarily it would be difficult to recruit enough 
volunteers meeting the stringent inclusion/exclusion criteria. I initiated a meeting 
with both Dr Gerhand and Professor Salkvoskis to discuss my concerns and it was 
agreed that the project, on reflection, would be unfeasible in the time available. This 
experience taught me the importance of considering feasibility of a project early on 
in the research process. I had to make an assertive decision to end the project, despite 
the significant amount of effort already invested; this was a difficult yet important 
decision allowing me time to develop a new project idea. 
 
From this point I met with the course team to decide the next course of action. I was 
aware of another Clinical Neuropsychologist in the area (Dr Leon Dysch) who was 
keen to co-develop a research project investigating psychological factors in 
Parkinson’s Disease. Through a series of meetings between myself, Dr Dysch and 
Professor Salkovskis I developed a project proposal, focussing primarily on 
evaluating the extent of health anxiety in patients with Parkinson’s Disease and the 
impact of health anxiety on psychological distress and quality of life. Initial 
conversations were also had around the relative contribution of another 
psychological construct, intolerance of uncertainty (IoU). Although not a primary 
focus, IoU remained a factor of interest in the final project. 
 
During the beginning of the second year I spent a significant amount of time 
building links with local Movement Disorder and Neurology centres; this involved 
several meetings with consultant physicians and attendance at regular team meetings. 
On reflection, this time invested in the early months of the project paid off. I was 
able to form good relationships with the teams who were extremely helpful 
throughout the course of the research in identifying and referring eligible 
participants.  
 
Seeking ethical approval for the project was a lengthy and sometimes complicated 
process. I had completed an NHS ethics application prior to training so knew that it 
could take a long time to complete and that it was important to factor this in. I was 
also aware of several trainee clinical psychologists in the previous cohort who had 




experienced difficulties with recruitment. I therefore ensured from the outset that I 
considered several potential recruitment sites, both NHS and third sector 
organisations (Parkinson’s UK).  
 
The course provided minimal teaching on applying for NHS ethics approval, 
although some useful information was provided in the programme handbook. I can 
imagine this would have been a challenge for individuals who were new to the 
process. I found the REC manager was an invaluable resource, particularly as the 
process of submission changed part way through applying. The process of attending 
a REC meeting and pitching my research proposal to the panel was a useful learning 
experience. 
 
My main project was ambitious and I was aware from the outset that a large amount 
of time would need to be invested into the data collection phase of the research. 
Indeed, each participant needed to be seen individually for a minimum of one hour 
(87 hours, excluding travel time). Participants were located across BANES and 
Wiltshire. Although tiring at times, I thoroughly enjoyed meeting participants and I 
feel I have gained valuable skills in conducting structured interviews and cognitive 
assessment within a research context. On reflection, it may have been useful to have 
requested the support of an Assistant Psychologist or Research Assistant. 
 
Service User Consultation 
Patients with Parkinson’s Disease were consulted during the piloting phase of the 
main research project. Their feedback regarding the experimental design was 
important in ensuring that all tasks could be administered in a timely and efficient 
manner and did not cause excessive fatigue or psychological distress.   
 
Unfortunately I was unable to involve service users in the development of my 
service improvement project. On reflection, it would appear that if service user 
feedback was to be effectively incorporated into the design of the research there 
would have needed to be consultation at a much earlier stage. On reflection, it 
occurred to me that it may have been helpful for service users to have been invited to 
the research fair during the first year of training. This would have allowed for 




conversations between local psychologists, training psychologists and service users 
regarding potential research ideas. This is something that I intend to feedback to the 
Programme. 
 
I am aware that the Bath Programme is working to increase service user involvement 
in the development of the programme; this includes incorporating service users in 
teaching as well as getting their input on the admissions process and programme 
curriculum. It would be helpful to incorporate service users in programme research 
and for the course to continue building links with local service user groups. 
 
Case Studies 
The work of the clinical psychologist is underpinned by the ability to apply 
psychological theory to practice. It requires the therapist to be flexible in applying 
their knowledge to best suit the needs of the client and to monitor and reflect on the 
progress of therapy. Completion of case studies throughout the course of training has 
been very useful in allowing me to demonstrate these clinical competencies. I have 
been able to complete case studies on a range of psychological difficulties, including 
PTSD, Blood-Injury and Injection (BII) phobia, GAD and OCD. Each case study 
involved the collection of regular outcome data with two studies utilising a single 
case experimental design. No statistical methods were used to analyse the data; 
however on reflection statistical tests such as the calculation of reliable and clinically 
significant change would have been useful in adding to the methodological rigor. 
The course requirement that case reports demonstrate heuristic value encouraged me 
to choose interesting and novel cases to write-up. These cases have contributed to the 
current evidence base and I have been able to disseminate the findings of these 
reports through conference presentations.  
 
Outcomes of Research 
I presented two case study poster presentations at the BABCP conference 2014, one 
of which was commended in the Excellence Awards. Further, my Service 
Improvement Project was presented at the European Cystic Fibrosis Conference in 
Gothenburg, Sweden 2014. 





I recently submitted abstracts for two further pieces of research to the upcoming 
BABCP conference 2015; both have been accepted. I plan to write up all my projects 
for submission to peer-review journals.  
 
Future Aspirations 
I will endeavour to continue conducting research and contributing to the literature on 
completion of doctoral training. I feel that my experiences developing and 
conducting research has helped me establish skills as a scientist-practitioner. As 
clinical psychologists, we are unique in having received advanced training in 
research design and development; these are valuable skills to take and share with 
future teams and colleagues.  
 
In the current economic climate, where NHS services are constantly being squeezed, 
and increasing pressures and demands are being placed on clinicians to produce 
outcomes, the opportunity and funding for research and service development is 
challenged. It will be important to be mindful of these challenges from the outset and 
to think of ways of ensuring that I can remain research active in future job roles. 
Indeed, it is during these times of increased pressure and cuts to funding that 
research and service evaluation are key. They allow services to take a step back and 
to think about how best to use resources to ensure efficient and effective running of 
services.  
 
I hope to maintain links with the programme, previous supervisors and to link in 
with local research networks. I hope to continue conducting research, audit and 
evaluation to produce service level change. As a qualified clinical psychologist I 
would be keen to supervise other trainee clinical psychologists and assistant 
psychologists in carrying out research. 
 
The clinical doctorate has provided opportunities to attend and have work presented 
at both national and international conferences, to share my experiences with other 
researchers and practitioners in the field, to acquire new knowledge and demonstrate 
theory-practice links. I hope to continue this post-qualifying.  
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this content.  
 
AudioSlides  
The journal encourages authors to create an AudioSlides presentation with their 
published article. AudioSlides are brief, webinar-style presentations that are shown 
next to the online article on ScienceDirect. This gives authors the opportunity to 
summarize their research in their own words and to help readers understand what the 
paper is about. More information and examples are available at 
http://www.elsevier.com/audioslides. Authors of this journal will automatically 
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Journal of Cystic Fibrosis 
Your Paper Your Way  
We now differentiate between the requirements for new and revised submissions. 
You may choose to submit your manuscript as a single Word or PDF file to be used 
in the refereeing process. Only when your paper is at the revision stage, will you be 
requested to put your paper in to a 'correct format' for acceptance and provide the 
items required for the publication of your article. To find out more, please visit the 
Preparation section below.  
Journal of Cystic Fibrosis publishes original scientific articles, editorials, case 
reports, short communications and other information relevant to cystic fibrosis and is 
published six times a year. Papers are accepted on the understanding that they have 
not been published, and are not being considered for publication elsewhere and are 
subject to editorial revision.  
Original articles  
Original research papers should contain no more than 3,000 words plus no more than 
5 figures or tables in total and 30 references. The abstract should consist of 4 
paragraphs, labelled Background, Methods, Results, and Conclusions.  
Review articles  
Review papers should be authoritative, well referenced reviews of a relevant subject 
and should not contain more than 5,000 words, and 30 references with no more than 
six figures or tables.  
Letters  
Headings should not be used in a letter; no abstract or keywords are required. The 
text should be no more than 800 words; there should be a maximum of 5 references 
and one table or figure may be included.  
Correspondence  
Short articles relating to papers recently published in the Journal, or containing brief 
reports of unusual or preliminary findings. Maximum length 400 words, one table or 
figure and a maximum of 10 references.  
Editorials  
These tend to be invited papers but unsolicited editorials are welcome. There are no 
abstract, keywords or section headings.  




Short Communications  
1,200 words plus no more than 3 figures or tables in total 20 references.  
Case Reports  
These must be carefully documented and must be of importance because they 
illustrate or describe unusual features or have important therapeutic implications. 
Maximum length 1200 words, no more than a page and a half in length and a 
maximum of 1 table or figure. Case reports do not require a structured abstract and 
should include no more than 5 references.  
Short Communication  
1,200 words plus no more than 3 figures or tables in total 20 references Page charges 
This journal has no page charges.  
BEFORE YOU BEGIN  
Ethics in publishing  
For information on Ethics in publishing and Ethical guidelines for journal 
publication see http://www.elsevier.com/publishingethics and 
http://www.elsevier.com/journal-authors/ethics. 
 Work on human beings that is submitted to Respiratory Medicine should comply 
with the principles laid down in the Declaration of Helsinki; Recommendations 
guiding physicians in biomedical research involving human subjects. Adopted by the 
18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th 
World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical 
Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, 
Hong Kong, September 1989. The manuscript should contain a statement that the 
work has been approved by the appropriate ethical committees related to the 
institution(s) in which it was performed and that subjects gave informed consent to 
the work. Studies involving experiments with animals must state that their care was 
in accordance with institution guidelines. Patients' and volunteers' names, initials, 
and hospital numbers should not be used.  
Conflict of interest  
All authors must disclose any financial and personal relationships with other people 
or organizations that could inappropriately influence (bias) their work. Examples of 
potential conflicts of interest include employment, consultancies, stock ownership, 
honoraria, paid expert testimony, patent applications/registrations, and grants or 
other funding. If there are no conflicts of interest then please state this: 'Conflicts of 
interest: none'. See also http://www.elsevier.com/conflictsofinterest. Further 
information and an example of a Conflict of Interest form can be found at:  






NEW SUBMISSIONS  
Submission to this journal proceeds totally online and you will be guided stepwise 
through the creation and uploading of your files. The system automatically converts 
your files to a single PDF file, which is used in the peer-review process. As part of 
the Your Paper Your Way service, you may choose to submit your manuscript as a 
single file to be used in the refereeing process. This can be a PDF file or a Word 
document, in any format or layout that can be used by referees to evaluate your 
manuscript. It should contain high enough quality figures for refereeing. If you 
prefer to do so, you may still provide all or some of the source files at the initial 
submission. Please note that individual figure files larger than 10 MB must be 
uploaded separately.  
References  
There are no strict requirements on reference formatting at submission. References 
can be in any style or format as long as the style is consistent. Where applicable, 
author(s) name(s), journal title/book title, chapter title/article title, year of 
publication, volume number/book chapter and the pagination must be present. Use of 
DOI is highly encouraged. The reference style used by the journal will be applied to 
the accepted article by Elsevier at the proof stage. Note that missing data will be 
highlighted at proof stage for the author to correct.  
Formatting requirements  
There are no strict formatting requirements but all manuscripts must contain the 
essential elements needed to convey your manuscript, for example Abstract, 
Keywords, Introduction, Materials and Methods, Results, Conclusions, Artwork and 
Tables with Captions. If your article includes any Videos and/or other 
Supplementary material, this should be included in your initial submission for peer 
review purposes. Divide the article into clearly defined sections 
Figures and tables embedded in text Please ensure the figures and the tables included 
in the single file are placed next to the relevant text in the manuscript, rather than at 
the bottom or the top of the file.  
Cover letter  
Corresponding authors must provide a cover letter which includes statements 
answering the following questions:  
•Has the work been seen and approved by all co-authors?  
•How is the work clinically relevant, and how does it add to existing research?  




•Have papers closely related to the submitted manuscript been published or 
submitted for publication elsewhere? If so please provide details. Failure to provide a 
cover letter addressing each of the questions above will result in the paper being 
returned to the author. The cover letter must be uploaded as a separate submission 
item. 
Essential title page information  
• Title. Concise and informative. Titles are often used in information-retrieval 
systems. Avoid abbreviations and formulae where possible.  
• Author names and affiliations. Please clearly indicate the given name(s) and family 
name(s) of each author and check that all names are accurately spelled. Present the 
authors' affiliation addresses (where the actual work was done) below the names. 
Indicate all affiliations with a lowercase superscript letter immediately after the 
author's name and in front of the appropriate address. Provide the full postal address 
of each affiliation, including the country name and, if available, the e-mail address of 
each author.  
• Corresponding author. Clearly indicate who will handle correspondence at all 
stages of refereeing and publication, also post-publication. Ensure that the e-mail 
address is given and that contact details are kept up to date by the corresponding 
author. • Present/permanent address. If an author has moved since the work 
described in the article was done, or was visiting at the time, a 'Present address' (or 
'Permanent address') may be indicated as a footnote to that author's name. The 
address at which the author actually did the work must be retained as the main, 
affiliation address. Superscript Arabic numerals are used for such footnotes. Avoid 
use of extraneous words such as "study" and "investigation". The title should be 
given in capital letters (not exceeding 100 letters), and a running title (not exceeding 
50 letters) should also be provided. If data from the manuscript have been presented 
at a meeting, list the full name, date and location of the meeting and reference any 
previous abstracts in the bibliography.  
Abstracts  
An abstract of your manuscript, summarizing the content, should be provided. A 
maximum of 150 words, should be written in a structured manner (for original 
articles only) since this will be the only part of the article studied by some readers. In 
original articles, the Abstract should consist of 4 paragraphs, labelled Background, 
Methods, Results, and Conclusions. They should briefly describe the problem being 
addressed in the study, how the study was performed and which measurements were 
carried out, the most relevant results, and what the authors conclude from the results. 
 
 





A list of three to six keywords should be supplied: full instructions are provided 
when submitting the article online  
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on 
the first page of the article. Such abbreviations that are unavoidable in the abstract 
must be defined at their first mention there, as well as in the footnote. Ensure 
consistency of abbreviations throughout the article.  
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the 
title or otherwise. List here those individuals who provided help during the research 
(e.g., providing language help, writing assistance or proof reading the article, etc.).  
Units  
Follow internationally accepted rules and conventions: use the international system 
of units (SI). If other units are mentioned, please give their equivalent in SI.  
Footnotes  
Footnotes should be used sparingly. Number them consecutively throughout the 
article. Many word processors build footnotes into the text, and this feature may be 
used. Should this not be the case, indicate the position of footnotes in the text and 
present the footnotes themselves separately at the end of the article.  
Artwork  
Electronic artwork  
General points  
• Make sure you use uniform lettering and sizing of your original artwork.  
• Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, 
Courier.  
• Number the illustrations according to their sequence in the text. • Use a logical 
naming convention for your artwork files.  
• Indicate per figure if it is a single, 1.5 or 2-column fitting image.  
• For Word submissions only, you may still provide figures and their captions, and 
tables within a single file at the revision stage.  




• Please note that individual figure files larger than 10 MB must be provided in 
separate source files. A detailed guide on electronic artwork is available on our 
website: http://www.elsevier.com/artworkinstructions. You are urged to visit this 
site; some excerpts from the detailed information are given here. Formats Regardless 
of the application used, when your electronic artwork is finalized, please 'save as' or 
convert the images to one of the following formats (note the resolution requirements 
for line drawings, halftones, and line/halftone combinations given below): EPS (or 
PDF): Vector drawings. Embed the font or save the text as 'graphics'. TIFF (or JPG): 
Color or grayscale photographs (halftones): always use a minimum of 300 dpi. TIFF 
(or JPG): Bitmapped line drawings: use a minimum of 1000 dpi. TIFF (or JPG): 
Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi 
is required.  
Please do not:  
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low.  
• Supply files that are too low in resolution.  
• Submit graphics that are disproportionately large for the content. Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), 
EPS (or PDF), or MS Office files) and with the correct resolution. If, together with 
your accepted article, you submit usable color figures then Elsevier will ensure, at no 
additional charge, that these figures will appear in color online (e.g., ScienceDirect 
and other sites) regardless of whether or not these illustrations are reproduced in 
color in the printed version. For color reproduction in print, you will receive 
information regarding the costs from Elsevier after receipt of your accepted article. 
Please indicate your preference for color: in print or online only. For further 
information on the preparation of electronic artwork, please see 
http://www.elsevier.com/artworkinstructions. 
Tables  
Please submit tables as editable text and not as images. Tables can be placed either 
next to the relevant text in the article, or on separate page(s) at the end. Number 
tables consecutively in accordance with their appearance in the text and place any 
table notes below the table body. Be sparing in the use of tables and ensure that the 
data presented in them do not duplicate results described elsewhere in the article. 
Please avoid using vertical rules.  
References  
Manuscripts should use the Vancouver style for references.  
Citation in text  




Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). Any references cited in the abstract must be given in full. 
Unpublished results and personal communications are not recommended in the 
reference list, but may be mentioned in the text. If these references are included in 
the reference list they should follow the standard reference style of the journal and 
should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item 
has been accepted for publication.  
Reference links  
Increased discoverability of research and high quality peer review are ensured by 
online links to the sources cited. In order to allow us to create links to abstracting 
and indexing services, such as Scopus, CrossRef and PubMed, please ensure that 
data provided in the references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link creation. When 
copying references, please be careful as they may already contain errors. Use of the 
DOI is encouraged.  
Web references  
As a minimum, the full URL should be given and the date when the reference was 
last accessed. Any further information, if known (DOI, author names, dates, 
reference to a source publication, etc.), should also be given. Web references can be 
listed separately (e.g., after the reference list) under a different heading if desired, or 
can be included in the reference list.  
Conflict of interest disclosure  
The Journal of Cystic Fibrosis has adopted the Conflict of Interest Disclosure form 
provided by the International Committee of Medical Journal Editors (ICMJI) and 
requests authors to complete it during the submission process; a copy of the form can 
be found here http://www.icmje.org/conflicts-of-interest/  
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the list (and 
any citations in the text) to other articles in the same Special Issue.  
Reference management software  
Most Elsevier journals have a standard template available in key reference 
management packages. This covers packages using the Citation Style Language, 
such as Mendeley (http://www.mendeley.com/features/reference-manager) and also 
others like EndNote (http://www.endnote.com/support/enstyles.asp) and Reference 
Manager 




Using plug-ins to word processing packages which are available from the above 
sites, authors only need to select the appropriate journal template when preparing 
their article and the list of references and citations to these will be formatted 
according to the journal style as described in this Guide. The process of including 
templates in these packages is constantly ongoing. If the journal you are looking for 
does not have a template available yet, please see the list of sample references and 
citations provided in this Guide to help you format these according to the journal 
style. If you manage your research with Mendeley Desktop, you can easily install the 
reference style for this journal by clicking the link below: 
http://open.mendeley.com/use-citation-style/journal-of-cystic-fibrosis When 
preparing your manuscript, you will then be able to select this style using the 
Mendeley plugins for Microsoft Word or LibreOffice. For more information about 
the Citation Style Language, visit http://citationstyles.org.  
Reference formatting 
There are no strict requirements on reference formatting at submission. References 
can be in any style or format as long as the style is consistent. Where applicable, 
author(s) name(s), journal title/book title, chapter title/article title, year of 
publication, volume number/book chapter and the pagination must be present. Use of 
DOI is highly encouraged. The reference style used by the journal will be applied to 
the accepted article by Elsevier at the proof stage. Note that missing data will be 
highlighted at proof stage for the author to correct. If you do wish to format the 
references yourself they should be arranged according to the following examples:  
Reference style  
Text: Indicate references by number(s) in square brackets in line with the text. The 
actual authors can be referred to, but the reference number(s) must always be given. 
List: Number the references (numbers in square brackets) in the list in the order in 
which they appear in the text.  
Examples:  
Reference to a journal publication:  
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. 
J Sci Commun 2010;163:51–9. 
Reference to a book:  
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 
2000.  
Reference to a chapter in an edited book:  
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: 
Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-




Publishing Inc; 2009, p. 281–304. Note shortened form for last page number. e.g., 
51–9, and that for more than 6 authors the first 6 should be listed followed by 'et al.' 
For further details you are referred to 'Uniform Requirements for Manuscripts 
submitted to Biomedical Journals' (J Am Med Assoc 1997;277:927–34)  
(see also http://www.nlm.nih.gov/bsd/uniform_requirements.html). 
Submission checklist  
The following list will be useful during the final checking of an article prior to 
sending it to the journal for review. Please consult this Guide for Authors for further 
details of any item.  
Ensure that the following items are present:  
One author has been designated as the corresponding author with contact details: 
• E-mail address  
• Full postal address  
All necessary files have been uploaded, and contain: 
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources 
(including the Internet) Printed version of figures (if applicable) in color or black-
and-white  
• Indicate clearly whether or not color or black-and-white in print is required.  
• For reproduction in black-and-white, please supply black-and-white versions of the 
figures for printing purposes. For any further information please visit our customer 
support site at http://support.elsevier.com. Additional Information Authors should 
use the 'Track Changes' option when revising their manuscripts, so that any changes 
made to the original submission are easily visible to the Editors. Those revised 
manuscripts upon which the changes are not clear may be returned to the author. 
Specific comments made in the Author Comments in response to referees' comments 
must be organised clearly. For example, use the same numbering system as the 



































Appendix C: Information relevant to ethical review (Service Improvement 
Project) 
 
This study was approved by the University Hospitals Bristol Questionnaire, 
Interview and Service (QIS) Committee on 7
th
 August 2013. Their approval process 
means that a reference number was not assigned, however my contact was Tony 
Watkin, Patient Experience Lead (Engagement and Involvement) at the University 
Hospitals Bristol NHS Foundation Trust.  
The Service Improvement Project received approval from The University of Bath 
Research Ethics Committee (reference number 13-117). In the absence of a letter, a 




















The following recommendations for service improvement were proposed; these were 
based on the results of the thematic analysis:  
 
1) Preparatory materials including reference to the medical, psychosocial and 
practical aspects of admission 
It is recommended that parents are provided with preparatory materials prior to 
admission, with particular reference made to the medical management of their 
child’s condition as well as the psychosocial and practical implications. Parents 
should be provided with advice on how to prepare their child for hospitalisation, 
what to expect from the hospital experience and information pertaining to the 
treatment and expected outcomes. These materials should be provided in sufficient 
time to allow parents to review the information and ask for clarity on aspects that are 
unclear. Preparatory materials are already in use in other countries (e.g., United 
States); please see www.choa.org for an example brochure.  
2) Pre-admission visit to the ward 
It is recommended that parents are given the opportunity to have a pre-admission 
visit to the ward in order to build familiarity with the setting and decrease anxiety. 
Alternatively, this information could be presented in the form of a virtual tour posted 
on the departmental or Trust website. 
3) Increasing the visibility of the paediatric CF team  
It is recommended that parents are made aware, prior to admission, that although 
their child will not be in the direct care of the CF team whilst on the ward, the CF 
team will be kept informed of their child’s progress through their attendance at 
weekly team meetings. It is recommended that a representative of the CF team takes 
an active role in attending weekly ward rounds to increase visibility of the team on 
the ward and answer any specific questions or concerns that parents may have.  
 




4) Increasing awareness of parental role on the ward and improving communication  
It is recommended that ward staff are made aware of the active role parent’s take in 
the day-to-day management of their child’s condition. Staff should discuss with 
parents to what extent they wish to be involved in their child’s care and facilitate any 

































Appendix E: Feedback to service (Service Improvement Project) 
 
Feedback to service 
 
The themes arising from the study were presented to the CF team as part of the 
monthly team meeting. Present were the consultant physician, dietician, senior nurse, 
team psychologist and physiotherapist. Recommendations were presented as 
preliminary ideas to then be elaborated. It was unanimously agreed that a preparatory 
material should be created and distributed to parents prior to admission. It was 
suggested by a number of team members that each specialty could contribute to the 
final document. There was discussion regarding the best time to distribute this; the 
general consensus was at a point in which hospitalisation for IV antibiotics was 
highly probable (i.e., when two courses of oral anti-biotics have proved 
unsuccessful). 
 
The team felt that there would be difficulty in arranging organised ward visits prior 
to admission due to challenges surrounding feasibility and confidentiality. However, 
it was agreed that there would be value in the service creating a virtual tour of the 
ward which could be uploaded onto the departmental or Trust website. The team 
physician noted the need to consult management regarding the implementation of 
this. 
 
Through discussion it was established there was certainly merit in a member of the 
CF team joining select ward rounds to improve team visibility. Further it would 
provide a point of contact for parents to raise specific questions or concerns they 
may have. It was highlighted that some parents reported feeling unable to discuss 
their concerns with members of the generic ward team.  
 
Finally, the CF team were in agreement with the need to include parents, where 
possible, in their child’s care whilst on the ward. The team raised awareness to the 
practical and ethical factors impacting on this and subsequently highlighted the need 
for staff to be more explicit prior to admission about the extent to which parents 
would be able to exert their role on the ward, thus setting realistic expectations. The 
need for more open and effective staff-patient communication in facilitating this 




process was discussed. Brief communication skills training to ward staff was 
proposed by the CF psychologist. The nursing staff suggested using ‘micro-teaches’ 
(10 minute teaching slots) or a ‘regional study day’ as potential forums for this. 
 
Further actions required 
 
 It was agreed that the CF Consultant Physician would speak with senior 
management regarding the development and implementation of a virtual tour 
on the departmental or Trust website. 
 The team psychologist agreed to develop a brochure in collaboration with all 
members of the CF team addressing the pre-hospitalisation information needs 
of parents. 
 The CF Consultant Physician agreed to liaise with both the CF and ward 
teams to set up joint weekly ward rounds.  
 The team psychologist agreed to liaise with the ward nursing team regarding 






















Appendix F: Instructions for authors for Main Research Project 
Journal of Parkinson’s Disease 
 




Organization and style of presentation  
 
Manuscripts must be written in English. Authors whose native language is not 
English are recommended to seek the advice of a native English speaker, if 
possible, before submitting their manuscripts.  
 
Manuscripts should be double spaced throughout with wide margins (2.5cm or 
1in), including the abstract and references. Every page of the manuscript, including 
the title page, references, tables, etc., should include a page number centered at the 
bottom.  
 
Manuscripts should be organized in the following order with headings and 




•Title (should be clear, descriptive and concise). 
 
•Full name(s) of author(s). 
 
•Full affiliation(s). Delineate affiliations with lowercase letters.  
 
•Present address of author(s), if different from affiliation. 
 
•Running title (45 characters or less, including spaces). 
 
•Complete correspondence address, including telephone number, fax number and 
e-mail address. 
 
Leave the author information blank if double-blind peer review is wished for, but 
do include the information in the submission letter to the editor. 
 
Abstract and Keywords  
 
















The abstract should try to be no longer than 250 words. 
 
For other papers such as Reviews, the abstract should be clear, descriptive, and 
self-explanatory, and no longer than 250 words. 
 





Materials and Methods  
 
There is no word limit to the materials and methods section, as the journal’s policy 






Acknowledgments including sources of support  
 
Conflict of Interest 
 
If there is no conflict of interest to declare, do still include this section and insert 




•Click here to download the EndNote reference style file for JPD articles. 
 
•Place citations as numbers in square brackets in the text. All publications cited in 
the text should be presented in a list of references following the text of the 
manuscript. Only articles published or accepted for publication should be listed in 
the reference list. Submitted articles can be listed in the text as (Author(s), 
unpublished data). 
 
•All authors should be listed in the reference list.  
 
•References should be listed in the order of appearance in the following style:  
 
 
[1]    Alzheimer Research Forum, Drugs in Clinical Trials: AAB-
001, http://www.alzforum.org/drg/drc/detail.asp?id=101, Last updated May 29, 




2007, Accessed on January 29, 2008.  
 
[2]    Smith MA (2006) Oxidative stress and iron imbalance in Alzheimer 
disease: how rust became the fuss! In Alzheimer's Disease: A Century of 
Scientific and Clinical Research, Perry G, Avila J, Kinoshita J, Smith MA, eds. 
IOS Press, Amsterdam, pp. 305-308. 
 
[3]    Hara H, Monsonego A, Yuasa K, Adachi K, Xiao X, Takeda S, Takahashi 
K, Weiner HL, Tabira T (2004) Development of a safe oral Abeta vaccine using 
recombinant adeno-associated virus vector for Alzheimer's disease. J Alzheimers 
Dis 6, 483-488.  
 
[4]    Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 
Academic Press, Sydney.  
 
[5]    Zhu X, Perry G, Smith MA (2004) Two hits and you're out? A novel 
mechanistic hypothesis of Alzheimer disease, Alzheimer Research 
Forum,http://www.alzforum.org/res/adh/cur/zhu/default.asp, Posted 23 October 




Number according to their sequence in the text. The text should include references 
to all tables.  
 
Provide each table on a separate page of the manuscript after the references.  
 
Include a brief and self-explanatory title with any explanations essential to the 
understanding of the table given in footnotes at the bottom of the table.  
 
Vertical lines should not be used to separate columns. Leave some extra space 




Number the figures according to their sequence in the text. The text should include 
references to all figures.  
 
For the file formats of the figures please take the following into account: 
 
•Line art should have a minimum resolution of 1200 dpi, save as EPS or TIFF. 
 
•Do not use faint lines and/or lettering and check that all lines and lettering 
within the figures are legible at final size. 
 
•All lines should be at least 0.1 mm (0.3 pt) wide. 
 
•Vector graphics containing fonts must have the fonts embedded in the files. 
 




•Grayscales (incl photos) should have a minimum resolution of 300 dpi, or 600 
dpi for combination art (lettering and images); save as TIFF. 
 
•Do not save figures as JPEG, this format may lose information in the process 
 
•Do not use figures taken from the Internet, the resolution will be too low for 
printing 
 
•Do not use color in your figures if they are to be printed in black & white, as 
this will reduce the print quality (note that in software often the default is color, 
you should change the settings) 
 
•For figures that should be printed in color, please send a CMYK encoded EPS 
or TIFF  
 
Figures should be designed with the format of JPD in mind and preferable sized as 
they will appear when printed. A single column of the journal is 77mm and two 
columns are 165mm.  
 
Figures should be cropped to include the figure only (no blank space). 
 
On figures where a scale is needed, use bar scales to avoid problems if the figure 
needs to be reduced.  
 
Each illustration should have a brief self-explanatory legend that should be typed 
separately from the figure in the section of the manuscript following the tables.  
 
Supplementary Data  
 
Supplementary data can be submitted with the manuscript, inserted at the end of 
the document. Legends should be included for each item. Each supplementary item 
should not exceed the file size of 10MB. Supplemental videos can also be 
submitted, and a title and legend should be included as Supplementary Material 
within the manuscript. Large datasets should be hosted on the author’s own or 









                                                  































































              
                 
Participant Information Sheet (Patient) 
 
Psychological factors in Parkinson’s disease  
 
Invitation to take part in a research project 
My name is Vera Hughes. I am a Clinical Psychologist in Training at the Department 
of Psychology, University of Bath, supervised by Professor Paul Salkovskis. I am 
currently working in collaboration with Dr Robin Fackrell (Consultant Physician), 
Dr Leon Dysch (Clinical Psychologist) and the Movement Disorders Team at Bath, 
conducting research into psychological factors in Parkinson’s disease. We would like 
to invite you to take part. 
Before deciding whether or not you would like to take part, we would ask that you 
read this information sheet which describes why we are doing this research project, 
and why it would involve you. Your participation in this project is completely 
voluntary; it is up to you to decide if you would like to take part. Your decision will 
not affect any treatment or care you are receiving, in any way. Even if you decide to 
participate in the project you are free to withdraw from it at any time and without 
giving a reason.    
Please take time to read the following information carefully and discuss it with 
others if you wish.  Ask us if there is anything that is not clear or if you would like 
more information.   
Why are we doing this research project?   
Parkinson’s disease is chronic and disabling condition. It can interfere hugely with a 
person’s life, affecting ones future goals and aspirations. It is understandable 
therefore that research indicates high levels of anxiety and depression among 
individuals with Parkinson’s disease. 
This study aims to further explore individuals’ reactions to Parkinson’s disease, 
looking specifically at anxiety relating to health and the impact of this on quality of 
life and well-being. This research will hopefully point the way forward for better 
treatment for patients with Parkinson’s disease who suffer from emotional distress. 





Why have I been chosen? 
You have been chosen to participate in the study because you have received a 
diagnosis of Parkinson’s disease. About 60 other people with Parkinson’s disease 
will take part in the research. 
Do I have to take part? 
It is up to you to decide whether or not to take part.  Your clinician will describe the 
study and go through this information sheet with you. If you decide to take part, you 
will be given this information sheet to keep. If you need more time to consider your 
participation, I can call you (with your permission) at a pre-arranged convenient 
time. You will still be free to withdraw at any time and without giving a reason.  A 
decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive. 
What will I be asked to do if I take part? 
I will arrange a research appointment with you, at a time that is convenient. You will 
be free to choose whether you would like for this to take place at home or at one of 
the hospital sites (St Martin’s Hospital or the Royal United Hospital, Bath). Prior to 
our appointment I will ask that you complete a short questionnaire pack which will 
include questions relating to the following topics: 
 
 You quality of life.  
 How anxious you are about your health. 
 General levels of anxiety and low mood. 
 Your physical disability due to having Parkinson’s disease. 
 
Completion of the questionnaire measures should take no longer than 35 minutes. 
You may wish to complete these at home alone, in the company of a friend or 
relative or bring them along to the research appointment, where I can assist you. 
During the research session you will be asked to complete two short tasks designed 
to evaluate the way your Parkinson’s disease is affecting you. One will be looking at 
your thinking skills and the second will measure your physical strength using what is 
called a hand grip dynamometer. This requires you to grip a lever and hold it while a 
measure is taken on a dial. In total the research session should take no more than 1 
hour.  
On completion of the study, a summary of the findings will be made available to you 
should you want a copy. The research team would like to offer you £5 towards 
parking and travelling expenses as a token of our appreciation. 
 
 





Your wellbeing, while participating in the project 
Participating in the study will involve some of your time to fill out questionnaires 
and tasks and may involve a trip to the hospital to complete these. This process 
might cause you to feel tired. Filling out questionnaires about low mood and anxiety 
can sometimes be distressing. If at any time you feel as if you have had enough of 
the questions, or begin to feel upset by them, please do stop. If you want to return 
after a break that would be fine, or if you didn’t want to do anymore that would be 
fine also. The top priority is your well-being. If you feel that you’d like to talk over 
any thoughts you have while filling out the questionnaires, or afterwards, I would be 
very happy to talk to you about this. If necessary, we can arrange access to support 
from a qualified Clinical Psychologist and/or your Consultant Physician. If the 
research team feel especially concerned about your wellbeing, then we will discuss 
this with you, your medical team and GP in order to determine your preferences and 
needs for additional support. 
What are the possible benefits of taking part? 
We cannot promise the study will help you directly but the information collected 
from you and other participants may help to us to provide better information and 
advice to people with Parkinson’s disease. A further benefit of this type of research 
will be to inform the application of psychological therapies.  
Will my taking part in this study be kept confidential? 
Information which is collected about you during the course of the research will be 
kept confidential and will conform to the Data Protection Act of 1998 with respect to 
data collection, storage and destruction. This means that all paper-based and 
electronic information will be locked and password protected with access restricted 
to study personnel and any information about you will have your name and address 
removed so that you cannot be identified from it.  The Research Governance Sponsor 
of this study, University of Bath, may monitor or audit this study to ensure that it is 
being conducted appropriately but your identity will not be revealed. 
We hope to report our findings in academic/health related journals and present them 
to relevant health professionals at meetings and conferences. The findings will also 
contribute to my Doctorate in Clinical Psychology. You will not be identified in any 
reports or publications arising from the study.  
Please note: there may be exceptional circumstances when confidential information 
may need to be released. For example, if there is reason to believe that there is a risk 
of significant harm to you or another person. Even in such exceptional cases we will 
always attempt to obtain your consent before disclosing any information. 
 





Who is funding this research? 
The research is being funded as part of the researcher’s Professional Doctorate in 
Clinical Psychology at the University of Bath. 
Who has reviewed the study? 
Full NHS ethical approval has been sought for this project (via an NHS Research 
Ethics Committee), along with local R&D approval from the relevant NHS Trusts 
and the University of Bath Department of Psychology ethics committee. 
 
What to do if there is a problem? 
 
If you have any concerns or wish to complain about any aspect of the way you have 
been approached or treated as part of this study, you should initially contact myself 
or my supervisor, Professor Paul Salkovskis. We will do our best to answer your 
questions (see contact details below). If you remain unhappy and wish to complain 
formally, you can do this through the Sirona Care and Health Customer Care 
Services (Details can be obtained from their website). 
 
In the unlikely event that something does go wrong and you are harmed during the 
research and this is due to someone‘s negligence then you may have grounds for a 
legal action for compensation against the University of Bath but you may have to 
pay your legal costs.  
 
Contact for Further Information 
If you think you might be interested in taking part, or have any questions about the 
project, please contact me on 07704517743 or by email: vch23@bath.ac.uk. 
Alternatively, contact Professor Paul Salkovskis (Course and Research Director) on 
01225 384350 or by email on: p.m.salkovskis@bath.ac.uk. 
Please keep this part of the sheet yourself for reference. Please feel free to ask any 
questions before you complete the consent form on the following page, and then 
return the completed consent form to the researcher (Vera Hughes). It will be stored 
separately form the anonymous information you provide for the research project.  



















Title of Project: Psychological factors in Parkinson’s disease  
Name of Researcher: Vera Hughes, Trainee Clinical Psychologist, supervised by 
Professor Paul Salkovskis (Course and Research Director) and Dr Leon Dysch 
(Clinical Psychologist) 
 
Please initial box 
 
1. I confirm that I have read and understand the Participant Information 
Sheet dated 30.06.14 (version 2) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason, without my 
medical care or legal rights being affected. 
 
3. I understand that data collected during the study, may be looked at 
by individuals from University of Bath, from regulatory authorities 
or from the NHS Trust, where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to 
this data. 
 
4. I agree that once I have completed the study, if I lose the capacity of 
consent, that my data will be retained by the researchers for analysis 
in an anonymised form 
 
5. I agree to take part in the above study. 













































Appendix J: Questionnaire Measures 
Permission to use the MDS-UPDRS was sought from the International Parkinson 
and Movement Disorder Society. All other questionnaire measures included in this 
section were freely available online.  
 
UPDRS Section II 
 
This questionnaire asks you about your experiences of daily living. There are 20 
questions. We are trying to be thorough, and some of these questions may 
therefore not apply to you now or ever. If you do not have the problem, simply 
mark 0 for NO. 
 
Please read each one carefully and read all answers before selecting the one that 
best applies to you, do this by circling the number that corresponds to your 
chosen response. We are interested in your average or usual function over the past 
week including today. Some patients can do things better at one time of the day 
than at others. However, only one answer is allowed for each question, so please 
mark the answer that best describes what you can do most of the time. 
 
You may have other medical conditions besides Parkinson’s disease (PD). Do not 
worry about separating Parkinson’s disease from other conditions. Just answer the 
question with your best response.  
 



























1. SLEEP PROBLEMS 
Over the past week, have you had trouble going to sleep at night or staying asleep 
through the night? Consider how rested you felt after waking up in the morning. 
 
 
2. DAYTIME SLEEPINESS 
Over the past week, have you had trouble staying awake during the daytime? 
 
0 No daytime sleepiness. 
 
1 Daytime sleepiness occurs but I can resist and I stay awake. 
 
2 Sometimes I fall asleep when alone and relaxing. For example, while 
reading or watching TV. 
 
3 I sometimes fall asleep when I should not. For example, while eating or 
talking with other people. 
 
4 I often fall asleep when I should not. For example, while eating or talking 













0 No problems. 
 
1 Sleep problems are present but usually do not cause trouble getting a full 
night of sleep. 
 
2 Sleep problems usually cause some difficulties getting a full night of sleep. 
 
3 Sleep problems cause a lot of difficulties getting a full night of sleep, but I 
still usually sleep for more than half the night. 
 
4 I usually do not sleep for most of the night. 
 





3. PAIN AND OTHER SENSATIONS 
Over the past week, have you had uncomfortable feelings in your body like pain, 
aches tingling or cramps? 
 
0 No uncomfortable feelings. 
 
1 I have these feelings. However, I can do things and be with other people 
without difficulty. 
 
2 These feelings cause some problems when I do things or am with other 
people. 
 
3 These feelings cause a lot of problems, but they do not stop me from 
doing things or being with other people. 
 
4 These feelings stop me from doing things or being with other People. 
 
 
4. URINARY PROBLEMS 
Over the past week, have you had trouble with urine control? For example, an 
urgent need to urinate, a need to urinate too often, or urine accidents? 
 
0 No urine control problems. 
 
1 I need to urinate often or urgently. However, these problems do not cause 
difficulties with my daily activities. 
2 Urine problems cause some difficulties with my daily activities. However, I 
do not have urine accidents. 
3 Urine problems cause a lot of difficulties with my daily activities, including 
urine accidents. 




















5. CONSTIPATION PROBLEMS 
Over the past week have you had constipation troubles that cause you difficulty 
moving your bowels? 
 
0 No constipation. 
 
1 I have been constipated. I use extra effort to move my bowels. However, 
this problem does not disturb my activities or my being comfortable. 
2 Constipation causes me to have some troubles doing things or being 
comfortable. 
 
3 Constipation causes me to have a lot of trouble doing things or being 
comfortable. However, it does not stop me from doing anything. 




6. LIGHT HEADEDNESS ON STANDING 
Over the past week, have you felt faint, dizzy or foggy when you stand up after 













0 No dizzy or foggy feelings. 
 
1 Dizzy or foggy feelings occur. However, they do not cause me troubles 
doing things. 
 
2 Dizzy or foggy feelings cause me to hold on to something, but I do not 
need to sit or lie back down. 
 
3 Dizzy or foggy feelings cause me to sit or lie down to avoid fainting or 
falling. 
 
4 Dizzy or foggy feelings cause me to fall or faint. 
 






Over the past week, have you usually felt fatigued? This feeling is not part of being 
sleepy or sad 
 
0 No fatigue. 
 
1 Fatigue occurs. However it does not cause me troubles doing things or 
being with people. 
 
2 Fatigue causes me some troubles doing things or being with people. 
 
3 Fatigue causes me a lot of troubles doing things or being with people. 
However, it does not stop me from doing anything. 





Over the past week, have you had problems with your speech? 
 
0 Not at all (no problems). 
 
1 My speech is soft, slurred or uneven, but it does not cause others to ask 
me to repeat myself. 
 
2 My speech causes people to ask me to occasionally repeat myself, but not 
every day. 
 
3 My speech is unclear enough that others ask me to repeat myself every 
day even though most of my speech is understood. 
 



















9. SALIVA & DROOLING 
Over the past week, have you usually had too much saliva during when you are 
awake or when you sleep? 
 
0 Not at all (no problems). 
 
1 I have too much saliva, but do not drool. 
 
2 I have some drooling during sleep, but none when I am awake. 
 
3 I have some drooling when I am awake, but I usually do not need tissues 
or a handkerchief. 
4 I have so much drooling that I regularly need to use tissues or a 
handkerchief to protect my clothes. 
 
 
10. CHEWING AND SWALLOWING 
Over the past week, have you usually had problems swallowing pills or eating 
meals? Do you need your pills cut or crushed or your meals to be made soft, 
chopped or blended to avoid choking? 
 
0 No problems. 
 
1 I am aware of slowness in my chewing or increased effort at swallowing, 
but I do not choke or need to have my food specially prepared. 
 
2 I need to have my pills cut or my food specially prepared because of 
chewing or swallowing problems, but I have not choked over the past 
week. 
 
3 I choked at least once in the past week. 
 


















11. EATING TASKS 
Over the past week, have you usually had troubles handling your food and using 
eating utensils? For example, do you have trouble handling finger foods or using 
forks, knifes, spoons, chopsticks? 
 
0 Not at all (No problems). 
 
1 I am slow, but I do not need any help handling my food and have not had 
food spills while eating. 
 
2 I am slow with my eating and have occasional food spills. I may need help 
with a few tasks such as cutting meat. 
3 I need help with many eating tasks but can manage some alone. 
 





Over the past week, have you usually had problems dressing? For example, are you 
slow or do you need help with buttoning, using zippers, putting on or taking off 
your clothes or jewellery? 
 
0 Not at all (no problems). 
 
1 I am slow but I do not need help. 
 
2 I am slow and need help for a few dressing tasks (buttons, bracelets). 
 
3 I need help for many dressing tasks. 
 




















Over the past week, have you usually been slow or do you need help with washing, 
bathing, shaving, brushing teeth, combing your hair or with other personal 
hygiene? 
 
0 Not at all (no problems). 
1 I am slow but I do not need any help. 
 
2 I need someone else to help me with some hygiene tasks. 
 
3 I need help for many hygiene tasks. 
 




Over the past week, have people usually had trouble reading your handwriting? 
 
0 Not at all (no problems). 
 
1 My writing is slow, clumsy or uneven, but all words are clear. 
 
2 Some words are unclear and difficult to read. 
 
3 Many words are unclear and difficult to read. 
 
4 Most or all words cannot be read. 
 
 
15. DOING HOBBIES AND OTHER ACTIVITIES 
Over the past week, have you usually had trouble doing your hobbies or other 
things 
that you like to do? 
 
0 Not at all (no problems). 
 
1 I am a bit slow but do these activities easily. 
 
2 I have some difficulty doing these activities. 
 
3 I have major problems doing these activities, but still do most. 
 
4 I am unable to do most or all of these activities. 
 
 






16. TURNING IN BED 
Over the past week, do you usually have trouble turning over in bed? 
 
0 Not at all (no problems). 
 
1 I have a bit of trouble turning, but I do not need any help. 
 
2 I have a lot of trouble turning and need occasional help from someone 
else. 
 
3 To turn over I often need help from someone else. 
 




Over the past week, have you usually had shaking or tremor? 
 
0 Not at all. I have no shaking or tremor. 
 
1 Shaking or tremor occurs but does not cause problems with any 
activities. 
 
2 Shaking or tremor causes problems with only a few activities. 
 
3 Shaking or tremor causes problems with many of my daily activities. 
 
4 Shaking or tremor causes problems with most or all activities. 
 
 
18. GETTING OUT OF BED, A CAR, OR A DEEP CHAIR 
Over the past week, have you usually had trouble getting out of bed, a car seat, or a 
deep chair? 
 
0 Not at all (no problems). 
 
1 I am slow or awkward, but I usually can do it on my first try. 
 
2 I need more than one try to get up or need occasional help. 
 
3 I sometimes need help to get up, but most times I can still do it on 
my own. 
 
4 I need help most or all of the time. 





19. WALKING AND BALANCE 
Over the past week, have you usually had problems with balance and walking? 
 
0 Not at all (no problems). 
 
1 I am slightly slow or may drag a leg. I never use a walking aid. 
 
2 I occasionally use a walking aid, but I do not need any help from another 
person. 
 
3 I usually use a walking aid (cane, walker) to walk safely without falling. 
However, I do not usually need the support of another person. 
 





Over the past week, on your usual day when walking, do you suddenly stop or 
freeze as if your feet are stuck to the floor. 
 
0 Not at all (no problems). 
 
1 I briefly freeze but I can easily start walking again. I do not need help from 
someone else or a walking aid (cane or walker) because of freezing. 
 
2 I freeze and have trouble starting to walk again, but I do not need 
someone’s help or a walking aid (cane or walker) because of freezing. 
 
3 When I freeze I have a lot of trouble starting to walk again and, because of 
freezing, I sometimes need to use a walking aid or need someone else’s 
help. 
 














Hospital Anxiety and Depression Scale (HADS) 
The 14 items below ask about your current mood and anxiety levels. Please read 
each item below and place a tick in the box next to the item that comes closest to 
how you have been feeling in the past week. Don’t take too long over your reply; 
















4. I can laugh and see the funny side 
of things 
  
As much as I always could  
Not quite so much now  
Definitely not so much now  




1. I feel tense or 'wound up'   
Most of the time  
A lot of the time  
From time to time, occasionally  
Not at all  
2. I still enjoy the things I used to 
enjoy 
  
Definitely as much  
Not quite so much  
Only a little  
Hardly at all  
3. I get a sort of frightened feeling 
as if something awful is about to 
happen 
  
Very definitely and quite badly  
Yes, but not too badly  
A little, but it doesn't worry me  
Not at all  




5. Worrying thoughts go through my 
mind 
  
A great deal of the time  
A lot of the time  
From time to time, but not too often  
Only occasionally  
 
6. I feel cheerful   
Not at all  
Not often  
Sometimes  






8. I feel as if I am slowed down   
Nearly all the time  
Very often  
Sometimes  
Not at all  
 
9. I get a sort of frightened feeling 
like 'butterflies' in the stomach 
  
Not at all  
Occasionally  
Quite Often  
Very Often  
 




I don't take as much care as I should  
I may not take quite as much care  
I take just as much care as ever  
 
 
7. I can sit at ease and feel relaxed   
Definitely  
Usually  
Not Often  
Not at all  




11. I feel restless as I have to be on 
the move 
  
Very much indeed  
Quite a lot  
Not very much  
Not at all  
 
12. I look forward with enjoyment 
to things 
  
As much as I ever did  
Rather less than I used to  
Definitely less than I used to  
Hardly at all  
 
13. I get sudden feelings of panic   
Very often indeed  
Quite often  
Not very often  
Not at all  
 
14. I can enjoy a good book or radio 




Not often  


















This questionnaire is asking about a general tendency to worry about one’s health, 
so the questions do not necessarily relate to worries about Parkinson’s disease 
(PD).  
 
Each question in this section consists of a group of four statements. Please read 
each group of statements carefully and then select the one which best describes 
your feelings, over the past six months. Identify the statement by circling the letter 
next to it e.g. if you think that statement (a) is correct, circle statement (a); it may 
be that more than one statement applies, in which case, please circle any that are 
applicable.  
 
1  (a) I do not worry about my health 
(b) I occasionally worry about my health 
(c) I spend much of my time worrying about my health 
(d) I spend most of my time worrying about my health 
 
2  (a) I notice aches/pains less than other people (of my age) 
(b) I notice aches/pains as much as most other people (of my age) 
(c) I notice aches/pains more than most other people (of my age) 
(d) I am aware of aches/pains in my body all the time 
 
3  (a) As a rule I am not aware of bodily sensations or changes 
(b) Sometimes I am aware of bodily sensations or changes 
(c) I am often aware of bodily sensations or changes 
(d) I am constantly aware of bodily sensations or changes 
 
4  (a) Resisting thoughts of illness is never a problem 
(b) Most of the time I can resist thoughts of illness 
(c)  I try to resist thoughts of illness but I am often unable to 
(d) Thoughts of illness are so strong that I no longer even try to resist 
them 
 






5  (a) As a rule I am not afraid that I have a serious illness [other than PD] 
(b) I am sometimes afraid that I have a serious illness [other than PD] 
(c) I am often afraid that I have a serious illness [other than PD] 
(d) I am always afraid that I have a serious illness [other than PD] 
 
6 (a) I do not have images (mental pictures) of myself being ill 
(b) I occasionally have images of myself being ill 
(c) I frequently have images of myself being ill 
(d) I constantly have images of myself being ill 
 
7  (a) I do not have any difficultly taking my mind off thoughts about my 
health 
(b) I sometimes have difficulty taking my mind off thoughts about my 
health 
(c) I often have difficulty taking my mind off thoughts about my health 
(d) Nothing can take my mind off thoughts about my health 
 
8 (a) I am lastingly relieved if my doctor tells me there is nothing wrong 
(b) I am initially relieved but worries sometimes return later 
(c) I am initially relieved but the worries always return later 
(d) I am not relieved if my doctor tells me there is nothing wrong 
 
9  (a) If I hear about an illness, other than PD, I never think I have it myself 
(b) If I hear about an illness, other than PD, I sometimes think I have it 
myself  
(c) If I hear about an illness, other than PD, I often think I have it myself 
(d) If I hear about an illness, other than PD, I always think I have it   
myself  





10 (a) If I have a bodily sensation or change I rarely wonder what it means 
(b) If I have a bodily sensation or change I often wonder what it means 
(c) If I have a bodily sensation or change I always wonder what it means 
(d) If I have a bodily sensation or change I must know what it means 
 
 
11 (a) I usually feel at very low risk for developing a serious illness [other 
than PD] 
(b) I usually feel at fairly low risk of developing a serious illness [other 
than PD] 
(c) I usually feel at moderate risk for developing a serious illness [other 
than PD] 
(d) I usually feel at high risk of developing a serious illness [other than 
PD] 
 
12 (a) I never think I have a serious illness, other than PD 
(b) I sometimes think I have a serious illness, other than PD 
(c) I often think I have a serious illness, other than PD 
(d) I usually think that I am seriously ill with something other than PD 
 
13 (a) If I notice an unexplained bodily sensation I never do anything to try 
and get   rid of it 
(b) If I notice an unexplained bodily sensation I sometimes try to get rid 
of it 
(c) If I notice an unexplained bodily sensation I often try to get rid of it 








14 (a) My family/friends would say I do not worry enough about my health 
(b) My family/friends would say I have a normal attitude to my health 
(c) My family/friends would say I worry too much about my health 






























You will find below a series of statements which describe how people may react to 
the uncertainties of life. Please use the scale below to describe to what extent each 




















1. Unforeseen events upset 
me greatly 
1 2 3 4 5 
2. It frustrates me not 
having all the 
information I need. 
1 2 3 4 5 
3. Uncertainty keeps me 
from living a full life. 
1 2 3 4 5 
4. One should always look 
ahead so as to avoid 
surprises. 
1 2 3 4 5 
5. A small unforeseen event 
can spoil everything, 
even with the best of 
planning. 
1 2 3 4 5 
6. When it’s time to act, 
uncertainty paralyses 
me. 
1 2 3 4 5 
7. When I am uncertain I 
can’t function very 
well. 
1 2 3 4 5 
8. I always want to know 
what the future has in 
store for me. 
1 2 3 4 5 
9. I can’t stand being taken 
by surprise. 
1 2 3 4 5 
10. The smallest doubt can 
stop me from acting. 
1 2 3 4 5 
11. I should be able to 
organize everything in 
advance. 
1 2 3 4 5 
12. I must get away from all 
uncertain situations. 
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